87333-19-5 | Ramipril

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$16.00	$11.00
1g	98%	in stock	$21.00	$15.00
5g	98%	in stock	$31.00	$22.00
25g	98%	in stock	$117.00	$82.00

Description

• Catalog Number: AB53932
• Chemical Name: Ramipril
• CAS Number: 87333-19-5
• Molecular Formula: C23H32N2O5
• Molecular Weight: 416.5106
• MDL Number: MFCD00865775
• SMILES: CCOC(=O)C(NC(C(=O)N1C2CCCC2CC1C(=O)O)C)CCc1ccccc1
• NSC Number: 758933

Computed Properties

• Complexity: 619
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 5
• Heavy Atom Count: 30
• Hydrogen Bond Acceptor Count: 6
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 10
• XLogP3: 1.4

Literature

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Contribution of human esterases to the metabolism of selected drugs of abuse.

  Toxicology letters 20150105

• Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.

  Fundamental & clinical pharmacology 20121201

• Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.

  Clinical science (London, England : 1979) 20121201

• The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes.

  Diabetes care 20121101

• Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.

  Journal of pharmaceutical and biomedical analysis 20121101

• Correlation between ultra-high performance liquid chromatography-tandem mass spectrometry and reversed-phase thin-layer chromatography hydrophobicity data for evaluation of angiotensin-converting enzyme inhibitors absorption.

  Journal of chromatography. A 20121005

• Palatability of crushed ß-blockers, converting enzyme inhibitors and thiazides.

  Journal of clinical pharmacy and therapeutics 20121001

• Trends in antihypertensives use among Moroccan patients.

  Pharmacoepidemiology and drug safety 20121001

• Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics.

  European heart journal 20121001

• [Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril].

  Giornale italiano di cardiologia (2006) 20121001

• Targeting platelet nitric oxide resistance with ramipril: unraveling mechanisms of atherothrombotic risk reduction with angiotensin-converting enzyme inhibitors.

  Journal of the American College of Cardiology 20120904

• Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients.

  Journal of the American College of Cardiology 20120904

• Effect of ramipril on the regulation of the expression of connexins 40 and 43 in a rabbit model of arterial balloon injury.

  Molecular medicine reports 20120901

• Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy.

  Herz 20120901

• Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120901

• The serum metabolomic study of intervention effects of the traditional Chinese medicine Shexiang Baoxin Pill and a multi-component medicine polypill in the treatment of myocardial infarction in rats.

  Molecular bioSystems 20120901

• The safe introduction of angiotensin-converting enzyme inhibitor in renal allograft recipients.

  Transplantation proceedings 20120901

• Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET).

  Circulation 20120821

• Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer.

  Journal of the American College of Cardiology 20120814

• Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetes.

  Acta diabetologica 20120801

• Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study.

  Journal of hypertension 20120801

• Long-term clinical experience with zofenopril.

  Expert review of cardiovascular therapy 20120801

• Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound.

  International journal of cardiology 20120712

• Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies.

  Journal of hypertension 20120701

• Obesity and oxidative stress predict AKI after cardiac surgery.

  Journal of the American Society of Nephrology : JASN 20120701

• Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment.

  Radiation research 20120701

• Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators.

  Circulation. Cardiovascular quality and outcomes 20120701

• Comparing effects of lacidipine, ramipril, and valsartan against experimentally induced myocardial infarcted rats.

  Cardiovascular toxicology 20120601

• Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.

  European heart journal 20120601

• Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy.

  Expert opinion on pharmacotherapy 20120601

• Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass.

  Clinical pharmacology and therapeutics 20120601

• Acute viral myopericarditis presenting as a transient effusive-constrictive pericarditis caused by coinfection with coxsackieviruses A4 and B3.

  The Korean journal of internal medicine 20120601

• Peripheral arterial disease of the lower extremities.

  Archives of medical science : AMS 20120509

• Animal models of cardiorenal syndrome: a review.

  Heart failure reviews 20120501

• Pierson syndrome in an adolescent girl with nephrotic range proteinuria but a normal GFR.

  Pediatric nephrology (Berlin, Germany) 20120501

• Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.

  Diabetologia 20120501

• Effect of ramipril on the electrophysiological characteristics of ventricular myocardium after myocardial infarction in rabbits.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20120501

• Prediction and prevention of atrial fibrillation in patients with high blood pressure or history of hypertension.

  Journal of hypertension 20120501

• Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.

  Journal of hypertension 20120501

• A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke.

  The Annals of pharmacotherapy 20120501

• [Training for LCA (Hope study)].

  La Revue du praticien 20120501

• Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120403

• Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.

  British journal of pharmacology 20120401

• A comparison between imidapril and ramipril on attenuation of ventricular remodeling after myocardial infarction.

  Journal of cardiovascular pharmacology 20120401

• Cost-effectiveness of chronic kidney disease mass screening test in Japan.

  Clinical and experimental nephrology 20120401

• Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.

  Experimental physiology 20120401

• Left bundle branch block, an old-new entity.

  Journal of cardiovascular translational research 20120401

• The influence of hip circumference on the relationship between abdominal obesity and mortality.

  International journal of epidemiology 20120401

• Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?

  Journal of hypertension 20120401

• Diabetes and hypertension: is there a common metabolic pathway?

  Current atherosclerosis reports 20120401

• Is there room for dual blockade of the renin-angiotensin-aldosterone system?

  Journal of hypertension 20120401

• Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

  European journal of heart failure 20120401

• Pattern of Angiotensin-converting enzyme inhibitors induced adverse drug reactions in South Indian teaching hospital.

  North American journal of medical sciences 20120401

• Effect of eplerenone, a selective aldosterone blocker, on the development of diabetic nephropathy in type 2 diabetic rats.

  Diabetes & metabolism journal 20120401

• Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation.

  Journal of cardiovascular pharmacology and therapeutics 20120301

• New roles for renin and prorenin in heart failure and cardiorenal crosstalk.

  Heart failure reviews 20120301

• Spectrofluorimetric determination of aliskiren in tablets and spiked human plasma through derivatization with dansyl chloride.

  Journal of fluorescence 20120301

• Influence of ramiprilat and losartan on ischemia reperfusion injury in rat hearts.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20120301

• Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.

  Diabetologia 20120301

• Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.

  Journal of molecular and cellular cardiology 20120301

• Increased cardiovascular risk in rats with primary renal dysfunction; mediating role for vascular endothelial function.

  Basic research in cardiology 20120301

• Clinical pharmacokinetics and pharmacodynamics of vildagliptin.

  Clinical pharmacokinetics 20120301

• Stress-induced cardiomyopathy presenting as ventricular tachycardia.

  The Korean journal of internal medicine 20120301

• Coarctation of the aorta.

  Archives of medical science : AMS 20120227

• Reduction in atherosclerotic events: a retrospective study in an outpatient cardiology practice.

  Archives of medical science : AMS 20120227

• Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot).

  International journal of cardiology 20120209

• Interstitial nephritis and autoimmune pancreatitis: a case report.

  International urology and nephrology 20120201

• Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

  Journal of the American Society of Nephrology : JASN 20120201

• The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel?

  Journal of the American Society of Nephrology : JASN 20120201

• Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.

  Bioorganic & medicinal chemistry letters 20120115

• Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).

  Journal of the American College of Cardiology 20120103

• Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.

  Cell and tissue research 20120101

• Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study.

  Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 20120101

• Efficacy and safety of aliskiren, a direct renin inhibitor, compared with ramipril in Asian patients with mild to moderate hypertension.

  Hypertension research : official journal of the Japanese Society of Hypertension 20120101

• Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents.

  Hypertension research : official journal of the Japanese Society of Hypertension 20120101

• Should all patients at high cardiovascular risk receive renin-angiotensin system blockers?

  QJM : monthly journal of the Association of Physicians 20120101

• Cultural Considerations: Pharmacological and Nonpharmacological Means for Improving Blood Pressure Control among Hispanic Patients.

  International journal of hypertension 20120101

• The Association between Hypertension and Dementia in the Elderly.

  International journal of hypertension 20120101

• Sodium intake, ACE inhibition, and progression to ESRD.

  Journal of the American Society of Nephrology : JASN 20120101

• Differential Impact of Stress Reduction Programs upon Ambulatory Blood Pressure among African American Adolescents: Influences of Endothelin-1 Gene and Chronic Stress Exposure.

  International journal of hypertension 20120101

• Sodium intake, ACE inhibition, and progression to ESRD.

  Journal of the American Society of Nephrology : JASN 20120101

• The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.

  Obstetrics and gynecology international 20120101

• Hypertension and dementia in the elderly: the leisure world cohort study.

  International journal of hypertension 20120101

• Ambulatory blood pressure monitoring in the elderly.

  International journal of hypertension 20120101

• Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study.

  Cardiovascular diabetology 20120101

• The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis.

  BMJ (Clinical research ed.) 20120101

• Amelioration of radiation-induced skin injury by adenovirus-mediated heme oxygenase-1 (HO-1) overexpression in rats.

  Radiation oncology (London, England) 20120101

• Severe lactic acidosis and acute renal failure following ingestion of metformin and kerosene oil: a case report.

  Journal of medical case reports 20120101

• Lipid disorders in elderly hypertensive patients.

  International journal of hypertension 20120101

• Activation of TRPV1 by capsaicin induces functional kinin B(1) receptor in rat spinal cord microglia.

  Journal of neuroinflammation 20120101

• Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials.

  Patient preference and adherence 20120101

• Preoperative proteinuria is associated with long-term progression to chronic dialysis and mortality after coronary artery bypass grafting surgery.

  PloS one 20120101

• Preventive pharmacotherapy in type 2 diabetes mellitus.

  Indian journal of endocrinology and metabolism 20120101

• Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review.

  Indian journal of endocrinology and metabolism 20120101

• An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic mice.

  Experimental diabetes research 20120101

• Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis.

  International journal of nephrology and renovascular disease 20120101

• Anesthetic management of a 137-year-old patient fracture of neck femur.

  Journal of anaesthesiology, clinical pharmacology 20120101

• Cardio classics revisited: focus on the role of amlodipine.

  Integrated blood pressure control 20120101

• Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy.

  Cardiology research and practice 20120101

• Spontaneous sinus conversion of permanent atrial fibrillation during treatment of hyperkalemia.

  Korean circulation journal 20120101

• Physician and patient predictors of evidence-based prescribing in heart failure: a multilevel study.

  PloS one 20120101

• Renal function and morphology in aged Beagle dogs before and after hydrocortisone administration.

  PloS one 20120101

• Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study.

  PloS one 20120101

• A different way of coronary lesion preparation: stentablation and rotastenting.

  Clinical Medicine Insights. Cardiology 20120101

• Therapeutic options for the treatment of hypertension in children and adolescents.

  Clinical medicine insights. Circulatory, respiratory and pulmonary medicine 20120101

• Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus.

  International journal of nanomedicine 20120101

• A young patient with heart failure: picture quiz question.

  Acute medicine 20120101

• Angiotensin receptor blockers in clinical practice--implications of the ONTARGET study.

  The Journal of international medical research 20120101

• Time trends in STEMI--improved treatment and outcome but still a gender gap: a prospective observational cohort study from the SWEDEHEART register.

  BMJ open 20120101

• New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil.

  Integrated blood pressure control 20120101

• The role of glucosamine-induced ER stress in diabetic atherogenesis.

  Experimental diabetes research 20120101

• Strategies to reverse endothelial progenitor cell dysfunction in diabetes.

  Experimental diabetes research 20120101

• The effect of antihypertensive drugs on endothelial function as assessed by flow-mediated vasodilation in hypertensive patients.

  International journal of vascular medicine 20120101

• Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.

  International journal of vascular medicine 20120101

• What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?

  Cardiovascular diabetology 20120101

• The metabolic syndrome and risk of chronic kidney disease: pathophysiology and intervention strategies.

  Journal of nutrition and metabolism 20120101

• Phenytoin in treatment of amiodarone-induced Torsades de pointes.

  Indian journal of pharmacology 20120101

• Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic heart failure.

  PloS one 20120101

• Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database.

  BMJ (Clinical research ed.) 20120101

• Emerging drug combinations to optimize renovascular protection and blood pressure goals.

  International journal of nephrology and renovascular disease 20120101

• Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.

  PloS one 20120101

• [Critically appraised article].

  Revista medica de Chile 20120101

• Regular exercise or changing diet does not influence aortic valve disease progression in LDLR deficient mice.

  PloS one 20120101

• The effect of admission creatinine levels on one-year mortality in acute myocardial infarction.

  TheScientificWorldJournal 20120101

• Assessing accuracy of an electronic provincial medication repository.

  BMC medical informatics and decision making 20120101

• Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men.

  PloS one 20120101

• Reviewing the medical literature: five notable articles in general internal medicine from 2010 and 2011.

  Open medicine : a peer-reviewed, independent, open-access journal 20120101

• Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.

  PloS one 20120101

• Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.

  Experimental diabetes research 20120101

• Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment.

  International journal of hypertension 20120101

• Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis.

  PloS one 20120101

• Acute pancreatitis induced by methimazole therapy.

  Case reports in gastroenterology 20120101

• Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial.

  BMJ (Clinical research ed.) 20120101

• Unmasking of tracheomalacia following short-term mechanical ventilation in a patient of adult respiratory distress syndrome.

  Indian journal of anaesthesia 20120101

• Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.

  Vascular health and risk management 20120101

• Antioxidants in kidney diseases: the impact of bardoxolone methyl.

  International journal of nephrology 20120101

• Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4).

  Clinical cardiology 20120101

• The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial.

  Journal of Alzheimer's disease : JAD 20120101

• Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients.

  ISRN pediatrics 20120101

• Factors that favor the occurrence of cough in patients treated with ramipril--a pharmacoepidemiological study.

  Medical science monitor : international medical journal of experimental and clinical research 20120101

• [Hypokalemic paralysis: the first presentation of primary Sjögren's syndrome].

  Acta medica portuguesa 20120101

• Renal outcome in equipotent antihypertensive treatment with telmisartan, ramipril and in combination in SHR-SP rats.

  Clinical laboratory 20120101

• [High blood pressure in the morning].

  MMW Fortschritte der Medizin 20111208

• Lichen planus pemphigoides induced by a weight reduction drug.

  Cutaneous and ocular toxicology 20111201

• Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension.

  Pediatric nephrology (Berlin, Germany) 20111201

• Optimization of cardiac metabolism in heart failure.

  Current pharmaceutical design 20111201

• Improvement of sodium status to optimize the efficacy of Renin-Angiotensin system blockade.

  Current hypertension reports 20111201

• Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

  Diabetologia 20111201

• De-novo headache with transient vertebro-basilar symptoms: role of embryonic hypoglossal artery.

  The journal of headache and pain 20111201

• Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up.

  European journal of internal medicine 20111201

• Telmisartan: just an antihypertensive agent? A literature review.

  Expert opinion on pharmacotherapy 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.

  European review for medical and pharmacological sciences 20111201

• Effects of ramipril and valsartan on proteinuria and renal function in patients with nondiabetic proteinuria.

  Collegium antropologicum 20111201

• What are the Evidence Based Public Health Interventions for Prevention and Control of NCDs in Relation to India?

  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 20111201

• Investigation of the effects of the chronic administration of some antihypertensive drugs on enzymatic and non-enzymatic oxidant/antioxidant parameters in rat ovarian tissue.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111101

• Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes.

  American journal of physiology. Renal physiology 20111101

• Relationship between QRS duration and left ventricular mass and volume in patients at high cardiovascular risk.

  Heart (British Cardiac Society) 20111101

• Ramipril modulates circadian gene expression in skeletal muscle.

  Pharmacogenetics and genomics 20111101

• Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

  European heart journal 20111101

• The carboxypeptidase ACE shapes the MHC class I peptide repertoire.

  Nature immunology 20111101

• The predicted impact of heart disease prevention and treatment initiatives on mortality in Lithuania, a middle-income country.

  Preventing chronic disease 20111101

• [Retinal microangiopathy in arterial hypertension as an early marker of a cerebral macroangiopathy].

  Deutsche medizinische Wochenschrift (1946) 20111101

• Azilsartan medoxomil: a new Angiotensin receptor blocker.

  Clinical therapeutics 20111101

• The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives.

  American heart journal 20111101

• A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy.

  The Indian journal of medical research 20111101

• Nonconvulsive status epilepticus in hepatic encephalopathy.

  The western journal of emergency medicine 20111101

• Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET).

  Circulation 20111018

• Is a blood pressure target of <130/80 mm Hg still appropriate for high-risk patients?

  Circulation 20111018

• Atrial fibrillation: the cost of illness in Sweden.

  The European journal of health economics : HEPAC : health economics in prevention and care 20111001

• Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition.

  Journal of the American Society of Nephrology : JASN 20111001

• Phosphate REINs in the renoprotective benefit of ACE inhibition.

  Journal of the American Society of Nephrology : JASN 20111001

• Telmisartan versus valsartan in patients with hypertension: effects on cardiovascular, metabolic, and inflammatory parameters.

  Korean circulation journal 20111001

• Cushing's surgery: Role of the anesthesiologist.

  Indian journal of endocrinology and metabolism 20111001

• Management of diabetic hypertensives.

  Indian journal of endocrinology and metabolism 20111001

• Bioequivalence study of 10 mg ramipril tablets in healthy Thai volunteers.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111001

• Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.

  European heart journal 20110901

• Ramiprilate inhibits functional matrix metalloproteinase activity in Crohn's disease fistulas.

  Basic & clinical pharmacology & toxicology 20110901

• Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.

  Journal of hypertension 20110901

• Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.

  Hypertension (Dallas, Tex. : 1979) 20110901

• Compliance, persistence, and switching patterns for ACE inhibitors and ARBs.

  The American journal of managed care 20110901

• Simultaneous estimation of ramipril, acetylsalicylic acid and atorvastatin calcium by chemometrics assisted UV-spectrophotometric method in capsules.

  Acta pharmaceutica (Zagreb, Croatia) 20110901

• [FARIM - FARmakoterapie po Infarktu Myokardu (Post-Myocardial Infarction Pharmacotherapy Study)].

  Vnitrni lekarstvi 20110901

• Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD.

  PLoS genetics 20110901

• Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?

  European journal of clinical pharmacology 20110801

• Telmisartan for the management of patients at high cardiovascular risk.

  Current medical research and opinion 20110801

• Target blood pressure in diabetes patients with hypertension--what is the accumulated evidence in 2011?

  Journal of Zhejiang University. Science. B 20110801

• Temporary bilateral sensorineural hearing loss following cardiopulmonary bypass -A case report-.

  Korean journal of anesthesiology 20110801

• Prevalence, Awareness, and Control of Hypertension among Diabetic Koreans.

  Diabetes & metabolism journal 20110801

• Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.

  The American journal of cardiology 20110715

• Fast gradient high performance liquid chromatography method with UV detection for simultaneous determination of seven angiotensin converting enzyme inhibitors together with hydrochlorothiazide in pharmaceutical dosage forms and spiked human plasma and urine.

  Talanta 20110715

• Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.

  Lancet (London, England) 20110709

• Primary stroke prevention and hypertension treatment: which is the first-line strategy?

  Neurology international 20110705

• Imaging findings in angiotensin-converting enzyme inhibitor induced angioedema.

  Emergency medicine journal : EMJ 20110701

• Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.

  Epidemiologic reviews 20110701

• Impact of acute kidney injury on clinical outcomes after ST elevation acute myocardial infarction.

  Yonsei medical journal 20110701

• Stroke management.

  Annals of Indian Academy of Neurology 20110701

• The significance of the j-curve in hypertension and coronary artery diseases.

  Korean circulation journal 20110701

• Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.

  Journal of diabetes science and technology 20110701

• Single coronary artery from the right sinus of Valsalva.

  Heart international 20110602

• Development and validation of UPLC tandem mass spectrometry assay for separation of a phase II metabolite of ramipril using actual study samples and its application to a bioequivalence study.

  Biomedical chromatography : BMC 20110601

• A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110601

• Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis.

  British journal of pharmacology 20110601

• Incidence of diabetes following ramipril or rosiglitazone withdrawal.

  Diabetes care 20110601

• ACE inhibition is renoprotective among obese patients with proteinuria.

  Journal of the American Society of Nephrology : JASN 20110601

• Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.

  Hypertension (Dallas, Tex. : 1979) 20110601

• Mixed messages on blood pressure goals.

  Hypertension (Dallas, Tex. : 1979) 20110601

• Autonomic imbalance: prophet of doom or scope for hope?

  Diabetic medicine : a journal of the British Diabetic Association 20110601

• Catheter-guided percutaneous heartworm removal using a nitinol basket in dogs with caval syndrome.

  Journal of veterinary science 20110601

• [Postpartum cardiomyopathy].

  Deutsche medizinische Wochenschrift (1946) 20110601

• REIN on obesity, proteinuria and CKD.

  Journal of the American Society of Nephrology : JASN 20110601

• Identification and management of albuminuria in the primary care setting.

  Journal of clinical hypertension (Greenwich, Conn.) 20110601

• Refractory hypertension and isosexual pseudoprecocious puberty associated with renin-secreting ovarian steroid cell tumor in a girl.

  Journal of Korean medical science 20110601

• European countries with small populations can obtain low prices for drugs: Lithuania as a case history.

  Expert review of pharmacoeconomics & outcomes research 20110601

• Telmisartan in high-risk cardiovascular patients. No need to change standard practice.

  Prescrire international 20110601

• New clinical concepts after the ONTARGET trial.

  Expert review of cardiovascular therapy 20110601

• Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data.

  Chinese medical journal 20110601

• Ramipril and risk of hyperkalemia in chronic hemodialysis patients.

  Collegium antropologicum 20110601

• Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease.

  Journal of managed care pharmacy : JMCP 20110601

• The effect of an Angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension.

  Diabetes & metabolism journal 20110601

• Ultra-thin-layer chromatography mass spectrometry and thin-layer chromatography mass spectrometry of single peptides of angiotensin-converting enzyme inhibitors.

  Journal of chromatography. A 20110520

• Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events.

  International journal of cardiology 20110519

• Heart failure prognostic model.

  Journal of medicine and life 20110515

• Development of a capillary electrophoresis method for the assay of ramipril and its impurities: an issue of cis-trans isomerization.

  Journal of chromatography. A 20110506

• Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices.

  European heart journal 20110501

• BR-squared: a practical solution to the winner's curse in genome-wide scans.

  Human genetics 20110501

• Hypertension augments cardiac Toll-like receptor 4 expression and activity.

  Hypertension research : official journal of the Japanese Society of Hypertension 20110501

• Rhythmic diurnal gene expression in human adipose tissue from individuals who are lean, overweight, and type 2 diabetic.

  Diabetes 20110501

• Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy.

  Diabetes care 20110501

• Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes.

  Diabetes care 20110501

• Type 2 diabetes can be prevented with early pharmacological intervention.

  Diabetes care 20110501

• Impact of methylation of acyl glucuronide metabolites on incurred sample reanalysis evaluation: ramiprilat case study.

  Bioanalysis 20110501

• Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells.

  Journal of clinical biochemistry and nutrition 20110501

• An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect.

  Clinics (Sao Paulo, Brazil) 20110501

• Telmisartan: a review of its use in cardiovascular disease prevention.

  Drugs 20110416

• The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.

  Journal of human hypertension 20110401

• Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection.

  Bioscience reports 20110401

• Unexpected hospitalisation side effects in an elderly man.

  Internal and emergency medicine 20110401

• Effects of commonly administered agents and genetics on nebivolol pharmacokinetics: drug-drug interaction studies.

  Journal of clinical pharmacology 20110401

• Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

  Biomedical chromatography : BMC 20110401

• Impact of nephron number dosing on cardiorenal damage and effects of ACE inhibition.

  American journal of hypertension 20110401

• Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications.

  American journal of hypertension 20110401

• Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.

  Blood pressure. Supplement 20110401

• Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.

  Clinical science (London, England : 1979) 20110401

• Asymmetric posterior reversible encephalopathy syndrome in patient with hyperplastic anterior choroidal artery.

  The journal of headache and pain 20110401

• Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial.

  Diabetes care 20110401

• Diabetes treatment and cardiovascular safety.

  Diabetes care 20110401

• Achieving blood preSsure goals sTudy in uncontrolled hypeRtensive pAtients treated with a fixed-dose combination of ramipriL/hydrochlorothiazide: the ASTRAL study.

  Cardiovascular journal of Africa 20110401

• [Renal amyloidosis: uncommon complication of sickle cell disease].

  Medecine tropicale : revue du Corps de sante colonial 20110401

• Acute pancreatitis and fibromyalgia: Cytokine link.

  North American journal of medical sciences 20110401

• Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.

  Circulation 20110315

• [Dental care with local anesthesia: should the patient first discontinue ACE inhibitors?].

  MMW Fortschritte der Medizin 20110303

• Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes.

  Diabetologia 20110301

• Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.

  Annals of internal medicine 20110301

• Telmisartan for the reduction of cardiovascular morbidity and mortality.

  Expert review of clinical pharmacology 20110301

• [Prevention of hypertension by drugs and immunization against angiotensin II].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20110210

• Using routinely collected prescribing data to determine drug persistence for the purpose of pharmacovigilance.

  Journal of clinical pharmacology 20110201

• Combined atorvastatin and ramipril mitigate radiation-induced impairment of dentate gyrus neurogenesis.

  Journal of neuro-oncology 20110201

• Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.

  British journal of pharmacology 20110201

• Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system.

  Journal of hypertension 20110201

• Treatment of heart failure with normal ejection fraction.

  Current treatment options in cardiovascular medicine 20110201

• Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril.

  International journal of clinical practice 20110201

• Type 2 diabetes: uses of thiazolidinediones and insulin.

  Diabetes care 20110201

• Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.

  Diabetes care 20110201

• 5-Fluorouracil-induced Tako-Tsubo-like syndrome.

  Pharmacotherapy 20110201

• World Kidney Day 2011 - Protect your kidneys, save your heart.

  Archives of medical science : AMS 20110201

• Simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma using liquid chromatography tandem mass spectrometry.

  Talanta 20110115

• Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina.

  Journal of human hypertension 20110101

• Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets.

  Molecular and cellular endocrinology 20110101

• Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.

  Journal of obesity 20110101

• ACE inhibitors for the treatment of hypertension drug selection by means of the SOJA method.

  Reviews on recent clinical trials 20110101

• Weight considerations in pharmacotherapy for type 2 diabetes.

  Journal of obesity 20110101

• Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.

  Diabetes care 20110101

• Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.

  The Lancet. Neurology 20110101

• Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients.

  Hypertension research : official journal of the Japanese Society of Hypertension 20110101

• Comparison of the effects of losartan vs. ramipril on several adipocytokines and vascular remodeling biomarkers.

  Hypertension research : official journal of the Japanese Society of Hypertension 20110101

• Compliance, persistence, healthcare resource use, and treatment costs associated with aliskiren plus ARB versus ACE inhibitor plus ARB combination therapy: in US patients with hypertension.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20110101

• Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome.

  International journal of nephrology 20110101

• Standards of medical care in diabetes--2011.

  Diabetes care 20110101

• Impact of ACE inhibitors on mortality and morbidity in patients with AMI: Does tissue selectivity matter?

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101

• Internet-based treatment for older adults with depression and co-morbid cardiovascular disease: protocol for a randomised, double-blind, placebo controlled trial.

  BMC psychiatry 20110101

• Heart-kidney interaction: epidemiology of cardiorenal syndromes.

  International journal of nephrology 20110101

• Resistant hypertension workup and approach to treatment.

  International journal of hypertension 20110101

• Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions.

  BMC nephrology 20110101

• Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.

  Cardiovascular diabetology 20110101

• Pharmacological and non-pharmacological interventions to influence adipose tissue function.

  Cardiovascular diabetology 20110101

• High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.

  PloS one 20110101

• Cardiorenal syndrome caused by heart failure with preserved ejection fraction.

  International journal of nephrology 20110101

• Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.

  International journal of nephrology 20110101

• ACE up the sleeve - are vascular patients medically optimized?

  Vascular health and risk management 20110101

• A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial.

  Trials 20110101

• Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review.

  Cardiology research and practice 20110101

• Spontaneous coronary artery dissection in a young man - case report.

  Journal of cardiothoracic surgery 20110101

• Telmisartan in incipient and overt diabetic renal disease.

  Journal of nephrology 20110101

• Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial.

  Trials 20110101

• Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.

  Cardiology research and practice 20110101

• Common secondary causes of resistant hypertension and rational for treatment.

  International journal of hypertension 20110101

• Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20110101

• Anastrozole-related acute hepatitis with autoimmune features: a case report.

  BMC gastroenterology 20110101

• Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care.

  BMC public health 20110101

• Treatment options for hypertension in high-risk patients.

  Vascular health and risk management 20110101

• Olmesartan/amlodipine: a review of its use in the management of hypertension.

  Vascular health and risk management 20110101

• Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.

  Cardiovascular diabetology 20110101

• Simultaneous, noninvasive, and transdermal extraction of urea and homocysteine by reverse iontophoresis.

  International journal of nanomedicine 20110101

• Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials.

  BMJ (Clinical research ed.) 20110101

• Cardiovascular and Renal Links along the Cardiorenal Continuum.

  International journal of nephrology 20110101

• Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?

  Parkinson's disease 20110101

• A validated densitometric method for analysis of atorvastatin calcium and metoprolol tartarate as bulk drugs and in combined capsule dosage forms.

  Journal of young pharmacists : JYP 20110101

• Rapid simultaneous determination of telmisartan, amlodipine besylate and hydrochlorothiazide in a combined poly pill dosage form by stability-indicating ultra performance liquid chromatography.

  Scientia pharmaceutica 20110101

• Combination delapril/manidipine as antihypertensive therapy in high-risk patients.

  Clinical drug investigation 20110101

• Reappraisal of role of angiotensin receptor blockers in cardiovascular protection.

  Vascular health and risk management 20110101

• A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors.

  Vascular health and risk management 20110101

• Peripheral vascular dysfunction in chronic kidney disease.

  Cardiology research and practice 20110101

• Salmonella enteritidis Infection Complicated by Acute Myocarditis: A Case Report and Review of the Literature.

  Cardiology research and practice 20110101

• Modulation of hemodynamics, endogenous antioxidant enzymes, and pathophysiological changes by Angiotensin-converting enzyme inhibitors in pressure-overload rats.

  Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20110101

• [Ten years after publishing results from The Heart Outcomes Prevention Evaluation Study--HOPE: implications on treatment with angiotensin converting enzyme inhibitors in clinical practice].

  Lijecnicki vjesnik 20110101

• An international randomised placebo-controlled trial of a four-component combination pill ('polypill') in people with raised cardiovascular risk.

  PloS one 20110101

• Collagenofibrotic glomerulopathy - Case report with review of literature.

  Indian journal of nephrology 20110101

• Into the future: prevention of diabetes.

  Contributions to nephrology 20110101

• Efficacy of aliskiren/hydrochlorothiazide combination for the treatment of hypertension: a meta-analytical approach.

  The open cardiovascular medicine journal 20110101

• Cardiac arrest caused by torsades de pointes tachycardia after successful atrial flutter radiofrequency catheter ablation.

  The open cardiovascular medicine journal 20110101

• A complex renal cyst: it is time to call the oncologist?

  International journal of nephrology 20110101

• Awareness of Abdominal Adiposity as a Cardiometabolic Risk Factor (The 5A Study): Mexico.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20110101

• The vulnerable plaque: the real villain in acute coronary syndromes.

  The open cardiovascular medicine journal 20110101

• Aliskiren: An orally active renin inhibitor.

  Journal of pharmacy & bioallied sciences 20110101

• Stroke, high blood pressure and the Renin-Angiotensin-aldosterone system - new developments.

  Frontiers in pharmacology 20110101

• Role of aliskiren in blood pressure control and renoprotection.

  International journal of nephrology and renovascular disease 20110101

• Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS).

  European journal of dermatology : EJD 20110101

• Critical appraisal of irrational drug combinations: A call for awareness in undergraduate medical students.

  Journal of pharmacology & pharmacotherapeutics 20110101

• Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study.

  BMC medicine 20110101

• Multiple unit particles system of ramipril: an approach to enhance stability.

  Journal of young pharmacists : JYP 20110101

• Hypertension in chronic kidney disease: navigating the evidence.

  International journal of hypertension 20110101

• Management of High Blood Pressure in Those without Overt Cardiovascular Disease Utilising Absolute Risk Scores.

  International journal of hypertension 20110101

• The mechanosensory role of primary cilia in vascular hypertension.

  International journal of vascular medicine 20110101

• Oxidative stress in cardiovascular inflammation: its involvement in autoimmune responses.

  International journal of inflammation 20110101

• New onset diabetes after transplantation (NODAT): an overview.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20110101

• Diabetic nephropathy - Epidemiology in Asia and the current state of treatment.

  Indian journal of nephrology 20110101

• Biological activities of chinese propolis and brazilian propolis on streptozotocin-induced type 1 diabetes mellitus in rats.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Management of Hypertension among Patients with Coronary Heart Disease.

  International journal of hypertension 20110101

• Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.

  BMJ (Clinical research ed.) 20110101

• Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

  BMJ (Clinical research ed.) 20110101

• Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

  Drug design, development and therapy 20110101

• Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials.

  Vascular health and risk management 20110101

• Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil.

  Vascular health and risk management 20110101

• Use of TIVA for Mandibular Plating in a Patient with Takayasu's Disease.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Perioperative atrial fibrillation in five patients - role of anxiety.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital.

  Annals of Saudi medicine 20110101

• Angiotensin-receptor blockade in acute stroke.

  Annals of Indian Academy of Neurology 20110101

• Animal models of calcific aortic valve disease.

  International journal of inflammation 20110101

• Neuroprotective effect of ACE inhibitors in glutamate - induced neurotoxicity: rat neuron culture study.

  Turkish neurosurgery 20110101

• Management of metformin-associated lactic acidosis by continuous renal replacement therapy.

  PloS one 20110101

• Effects of angiotensin-converting enzyme inhibitors beyond lowering blood pressure--are they important for doctors?

  Pharmacological reports : PR 20110101

• Role of Bone Morphogenetic Proteins-7 (BMP-7) in the Renal Improvement Effect of DangGui (Angelica sinensis) in Type-1 Diabetic Rats.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• ARBs for cardiovascular and renal protection in high-risk patients.

  Cardiovascular journal of Africa 20110101

• Trends in the Use of Evidence-based Therapies Early in the Course of Acute Myocardial Infarction and its Influence on Short Term Patient Outcomes.

  The open cardiovascular medicine journal 20110101

• Validated RP-HPLC Method for Simultaneous Quantitation of Losartan Potassium and Metolazone in Bulk Drug and Formulation.

  Scientia pharmaceutica 20110101

• Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.

  PloS one 20110101

• Anesthetic management for laparoscopy surgery in a patient with residual coarctation of aorta and mild aortic stenosis.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Formulation and evaluation of solid lipid nanoparticles of ramipril.

  Journal of young pharmacists : JYP 20110101

• Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models.

  PloS one 20110101

• Rituximab resistant evans syndrome and autoimmunity in Schimke immuno-osseous dysplasia.

  Pediatric rheumatology online journal 20110101

• Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study.

  BMC nephrology 20110101

• Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients.

  BMC cardiovascular disorders 20110101

• Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor.

  Therapeutics and clinical risk management 20110101

• Long-term use and tolerability of irbesartan for control of hypertension.

  Integrated blood pressure control 20110101

• Clinical utility of fixed-combination telmisartan-amlodipine in the treatment of hypertension.

  Integrated blood pressure control 20110101

• Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients.

  Integrated blood pressure control 20110101

• The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study.

  Journal of medical economics 20110101

• Inhibition of cardiac sympathetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure.

  PloS one 20110101

• Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in The Netherlands--a Markov model.

  PloS one 20110101

• Appreciating the medical literature: five notable articles in general internal medicine from 2009 and 2010.

  Open medicine : a peer-reviewed, independent, open-access journal 20110101

• Synchronous fluorescence spectrofluorimetric method for the simultaneous determination of metoprolol and felodipine in combined pharmaceutical preparation.

  Chemistry Central journal 20110101

• Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008.

  PloS one 20110101

• Myocardial recovery in peri-partum cardiomyopathy after continuous flow left ventricular assist device.

  Journal of cardiothoracic surgery 20110101

• Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo.

  PloS one 20110101

• Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk.

  Vascular health and risk management 20110101

• A case report and brief review of the literature on bilateral retinal infarction following cardiopulmonary bypass for coronary artery bypass grafting.

  Journal of cardiothoracic surgery 20110101

• Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance.

  Lipids in health and disease 20110101

• The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial.

  Trials 20110101

• Single coronary artery with anomalous rising of the right coronary artery: a rare coronary anomaly diagnosed by 256-multidetector computed tomography.

  Case reports in medicine 20110101

• A cluster randomised pragmatic trial applying Self-determination theory to type 2 diabetes care in general practice.

  BMC family practice 20110101

• Peritoneal Dialysis Drop-out: Causes and Prevention Strategies.

  International journal of nephrology 20110101

• Transforming growth factor β₁ oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart.

  PloS one 20110101

• Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors.

  Fibrogenesis & tissue repair 20110101

• Telmisartan and cardioprotection.

  Vascular health and risk management 20110101

• Zofenopril and incidence of cough: a review of published and unpublished data.

  Therapeutics and clinical risk management 20110101

• Combining antihypertensive and antihyperlipidemic agents - optimizing cardiovascular risk factor management.

  Integrated blood pressure control 20110101

• Medical angioplasty - hope and expectations: an optimistic overview.

  Journal of family & community medicine 20110101

• The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population.

  BMJ open 20110101

• Systematic drug repositioning based on clinical side-effects.

  PloS one 20110101

• The case for an elderly targeted stroke management.

  Frontiers in neurology 20110101

• TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats.

  International journal of hypertension 20110101

• Critical review of cancer risk associated with angiotensin receptor blocker therapy.

  Vascular health and risk management 20110101

• Benefits of once-daily therapies in the treatment of hypertension.

  Vascular health and risk management 20110101

• Effect of ramipril therapy on abnormal left atrial appendage function.

  The Journal of international medical research 20110101

• Thrombotic occlusion of all left coronary branches in a young woman with severe ulcerative colitis.

  ISRN cardiology 20110101

• Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion.

  ISRN cardiology 20110101

• Neurosurgery in an octogenarian with dementia.

  The Ulster medical journal 20110101

• Optimal management of peripheral arterial disease for the non-specialist.

  The Ulster medical journal 20110101

• Growth hormone deficiency, short stature, and juvenile rheumatoid arthritis in a patient with autoimmune polyglandular syndrome type 1: case report and brief review of the literature.

  ISRN endocrinology 20110101

• Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study.

  ISRN endocrinology 20110101

• Life-threatening hyponatraemia.

  BMJ case reports 20110101

• [Primary and secondary prevention of ischemic stroke].

  Le Journal medical libanais. The Lebanese medical journal 20110101

• Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).

  The Cochrane database of systematic reviews 20101208

• Soybeans ameliolate diabetic nephropathy in rats.

  Evidence-based complementary and alternative medicine : eCAM 20101201

• Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial.

  Cardiovascular therapeutics 20101201

• Spontaneous resolution of severe mitral regurgitation in a patient with a flail mitral valve.

  Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20101201

• Regression of target organ damage in children and adolescents with primary hypertension.

  Pediatric nephrology (Berlin, Germany) 20101201

• Differences between zofenopril and ramipril, two ACE inhibitors, on cough induced by citric acid in guinea pigs: role of bradykinin and PGE2.

  Naunyn-Schmiedeberg's archives of pharmacology 20101201

• Ramipril-like activity of Spondias mombin linn against no-flow ischemia and isoproterenol-induced cardiotoxicity in rat heart.

  Cardiovascular toxicology 20101201

• Inhibition of chymase protects against diabetes-induced oxidative stress and renal dysfunction in hamsters.

  American journal of physiology. Renal physiology 20101201

• Effects of zofenopril and ramipril on cough reflex responses in anesthetized and awake rabbits.

  Journal of cardiovascular pharmacology and therapeutics 20101201

• Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some?

  Diabetes, obesity & metabolism 20101201

• Dual renin-angiotensin system blockade for patients with prosthesis-patient mismatch.

  The Annals of thoracic surgery 20101201

• A novel analytical approach for reducing the consumption of organic solvents in the charge transfer-based spectrophotometric analysis: application in the analysis of certain antihypertensive drugs.

  Acta pharmaceutica (Zagreb, Croatia) 20101201

• Triple Combination Therapy Using Metformin, Thiazolidinedione, and a GLP-1 Analog or DPP-IV Inhibitor in Patients with Type 2 Diabetes Mellitus.

  Korean diabetes journal 20101201

• Simvastatin, sildenafil and their combination in monocrotaline induced pulmonary arterial hypertension.

  Korean circulation journal 20101201

• Heart failure--concepts and significance. Birth of a prognostic model.

  Journal of medicine and life 20101115

• Diagnosis of early myocarditis after respiratory or gastrointestinal tract viral infection: insights from cardiovascular magnetic resonance.

  Clinical research in cardiology : official journal of the German Cardiac Society 20101101

• Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker for the prevention of type 2 diabetes mellitus?

  Diabetes research and clinical practice 20101101

• Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together?

  Current vascular pharmacology 20101101

• Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy.

  Diabetes care 20101101

• The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus.

  Current cardiology reports 20101101

• Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database.

  Journal of hypertension 20101101

• Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study.

  Journal of hypertension 20101101

• Immobilization stress induces endothelial dysfunction by oxidative stress via the activation of the angiotensin II/its type I receptor pathway.

  Atherosclerosis 20101101

• The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice.

  European journal of heart failure 20101101

• Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

  Diabetic medicine : a journal of the British Diabetic Association 20101101

• A case of acute myocarditis caused by pandemic (H1N1) 2009 influenza virus.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20101101

• Strategies for initial management of hypertension.

  The Indian journal of medical research 20101101

• Congestive heart failure in Indians: how do we improve diagnosis & management?

  The Indian journal of medical research 20101101

• Diabetes & coronary heart disease: current perspectives.

  The Indian journal of medical research 20101101

• Aliskiren: a review of its use as monotherapy and as combination therapy in the management of hypertension.

  Drugs 20101022

• CORD: COmparison of Recommended Doses of ace inhibitors and angiotensin II receptor blockers.

  International journal of cardiology 20101008

• Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20101001

• Incidence, severity, and etiology of drug-induced acute pancreatitis.

  Digestive diseases and sciences 20101001

• Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).

  Diabetes care 20101001

• Interactions among related genes of renin-angiotensin system associated with type 2 diabetes.

  Diabetes care 20101001

• Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.

  Diabetes care 20101001

• Sitagliptin-induced hemolysis.

  Indian journal of pharmacology 20101001

• Angiotensin converting enzyme gene polymorphism and influence of ACE inhibition.

  Indian journal of nephrology 20101001

• Determination of pK(a) values of some antihypertensive drugs by liquid chromatography and simultaneous assay of lercanidipine and enalapril in their binary mixtures.

  Talanta 20100915

• Aliskiren for geriatric lowering of systolic hypertension: a randomized controlled trial.

  Journal of human hypertension 20100901

• Have we fallen off target with concerns surrounding dual RAAS blockade?

  Kidney international 20100901

• Cutting through the statistical fog: understanding and evaluating non-inferiority trials.

  International journal of clinical practice 20100901

• Effectiveness, safety and cost of drug substitution in hypertension.

  British journal of clinical pharmacology 20100901

• Diabetes and heart failure in patients with coronary disease: separating markers from mediators.

  Diabetes care 20100901

• cis9, trans11-Conjugated Linoleic Acid Differentiates Mouse 3T3-L1 Preadipocytes into Mature Small Adipocytes through Induction of Peroxisome Proliferator-activated Receptor γ.

  Journal of clinical biochemistry and nutrition 20100901

• Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study.

  Chronobiology international 20100901

• Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.

  Kardiologia polska 20100901

• ACE inhibition reduces infarction in normotensive but not hypertensive rats: correlation with cortical ACE activity.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20100801

• The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study.

  Diabetes 20100801

• Drug mechanisms to help in managing resistant hypertension in obesity.

  Current hypertension reports 20100801

• Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.

  Current diabetes reports 20100801

• Polypill: lights and shadows.

  Current hypertension reports 20100801

• Counterpoint: postprandial glucose levels are not a clinically important treatment target.

  Diabetes care 20100801

• Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences.

  Current cardiology reviews 20100801

• Heart failure in acute ischemic stroke.

  Current cardiology reviews 20100801

• Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report.

  Viruses 20100801

• Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?

  Drugs 20100709

• [Relation between defined daily doses (DDD) and prescribed daily doses: a 3-month analysis of outpatient data from a statutory health insurance company].

  Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 20100701

• Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100701

• Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100701

• Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.

  Diabetologia 20100701

• Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study.

  Diabetes care 20100701

• Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway.

  Transplant immunology 20100701

• Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.

  American journal of nephrology 20100701

• Reduced cerebrovascular remodeling and functional impairment in spontaneously hypertensive rats following combined treatment with suboptimal doses of telmisartan and ramipril: is less really more?

  Journal of hypertension 20100701

• Marfan syndrome and focal segmental glomerulosclerosis: a novel association.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20100701

• Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.

  Journal of hypertension 20100701

• Angiotensin-converting enzyme inhibitors and angioedema.

  Allergy, asthma & immunology research 20100701

• [Improvement of left ventricular function during combined carvedilol, ramipril and spironolactone therapy after myocarditis in patient treated earlier by chemotherapy due to Hodgkin's lymphoma - 3-years follow-up].

  Kardiologia polska 20100701

• Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor & angiotensin receptor blocker in type 1 DM with nephropathy.

  The Indian journal of medical research 20100701

• Reversible fetal renal failure after maternal treatment with Candesartan: a case report.

  Reproductive toxicology (Elmsford, N.Y.) 20100601

• Parity, breastfeeding, and the subsequent risk of maternal type 2 diabetes.

  Diabetes care 20100601

• Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis.

  Diabetologia 20100601

• Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2010: ACCORD, INVEST, NAVIGATOR, RACE II, SORT OUT III, CSP-474, DOSE, ASPIRE and more.

  Clinical research in cardiology : official journal of the German Cardiac Society 20100601

• Aliskiren versus ramipril in hypertension.

  Therapeutic advances in cardiovascular disease 20100601

• Kidney function in metabolic syndrome may be improved with Pycnogenol®.

  Panminerva medica 20100601

• Sensitivity enhancement and matrix effect evaluation during summation of multiple transition pairs-case studies of clopidogrel and ramiprilat.

  Biomedical chromatography : BMC 20100501

• Glomerular disease: ACEIs with or without corticosteroids in IgA nephropathy?

  Nature reviews. Nephrology 20100501

• Importance of a fixed combination of telmisartan and amlodipine for the treatment of hypertension.

  Drugs of today (Barcelona, Spain : 1998) 20100501

• Age-related short-term effect of ramipril on N-terminal pro-brain natriuretic peptide and markers of hemostasis in patients after acute myocardial infarction.

  Wiener klinische Wochenschrift 20100501

• Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.

  PLoS medicine 20100501

• Concomitant administration of simvastatin and danazol associated with fatal rhabdomyolysis.

  Clinical therapeutics 20100501

• Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.

  International journal of cardiology 20100401

• Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery.

  Journal of cardiothoracic and vascular anesthesia 20100401

• Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension.

  Journal of human hypertension 20100401

• Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance.

  Diabetes care 20100401

• Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

  European heart journal 20100401

• Radioprotectors and mitigators of radiation-induced normal tissue injury.

  The oncologist 20100401

• Utilization of cardiovascular drugs in Zagreb 2001-2005.

  Acta cardiologica 20100401

• Application of direct renin inhibition to chronic kidney disease.

  Cardiovascular drugs and therapy 20100401

• Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials.

  Circulation 20100330

• Images in cardiovascular medicine. Wide-field scanning laser ophthalmoscope imaging and angiography of central retinal vein occlusion.

  Circulation 20100330

• Ramipril in the treatment of proteinuria in children after renal transplantation.

  Pediatric transplantation 20100301

• Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial.

  Diabetes care 20100301

• Kidney flow and function in hypertension: protective effects of pycnogenol in hypertensive participants--a controlled study.

  Journal of cardiovascular pharmacology and therapeutics 20100301

• Blood pressure and diabetic nephropathy.

  Diabetes care 20100301

• Effects of ramipril on serum monocyte chemoattractant protein 1, interleukin-18, and interleukin-10 in elderly patients with acute coronary syndrome.

  Heart and vessels 20100301

• New data on ONTARGET: more confusion?

  Journal of clinical hypertension (Greenwich, Conn.) 20100301

• Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.

  Nephrology (Carlton, Vic.) 20100301

• Comparative effect of Ocimum sanctum, Commiphora mukul, folic acid and ramipril on lipid peroxidation in experimentally-induced hyperlipidemia.

  Indian journal of experimental biology 20100301

• Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.

  Journal of human hypertension 20100201

• Intense lorazepam-induced sexual arousal.

  Progress in neuro-psychopharmacology & biological psychiatry 20100201

• alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.

  Journal of molecular medicine (Berlin, Germany) 20100201

• Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein.

  Diabetes care 20100201

• Human recombinant ACE2 reduces the progression of diabetic nephropathy.

  Diabetes 20100201

• Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.

  Cardiovascular drugs and therapy 20100201

• [Renal effects of combined anti-hypertensive treatments].

  Recenti progressi in medicina 20100201

• Regulation of glucose control in people with type 2 diabetes: a review and consensus.

  Korean diabetes journal 20100201

• Adverse drug reaction monitoring with angiotensin converting enzyme inhibitors: A prospective, randomized, open-label, comparative study.

  Indian journal of pharmacology 20100201

• A suspected case of carbimazole-associated torsades de pointes.

  Indian journal of pharmacology 20100201

• Angina in Women without Obstructive Coronary Artery Disease.

  Current cardiology reviews 20100201

• Spectrofluorimetric assessment of Ramipril using optical sensor Samarium ion-doxycycline complex doped in sol-gel matrix.

  Journal of pharmaceutical and biomedical analysis 20100105

• Cardiovascular disease risk factors: epidemiology and risk assessment.

  The American journal of cardiology 20100104

• Are there effects of renin-angiotensin system antagonists beyond blood pressure control?

  The American journal of cardiology 20100104

• Renin-angiotensin system blockade and cardiovascular and renal protection.

  The American journal of cardiology 20100104

• Telmisartan in high-risk cardiovascular patients.

  The American journal of cardiology 20100104

• Ramipril-induced generalized pustular psoriasis: case report and literature review.

  American journal of therapeutics 20100101

• Many Americans have pre-diabetes and should be considered for metformin therapy.

  Diabetes care 20100101

• Is therapy of people with chronic kidney disease ONTARGET?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100101

• Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials.

  Hypertension (Dallas, Tex. : 1979) 20100101

• Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy.

  Current medical research and opinion 20100101

• ONTARGET should not be over interpreted.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100101

• Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both?

  Future cardiology 20100101

• Standards of medical care in diabetes--2010.

  Diabetes care 20100101

• Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.

  BMJ (Clinical research ed.) 20100101

• Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure.

  PloS one 20100101

• Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrus.

  Radiation oncology (London, England) 20100101

• Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery.

  BMC cardiovascular disorders 20100101

• [An experience with the use of direct renin inhibitor aliskiren in a patient with obesity and arterial hypertension].

  Kardiologiia 20100101

• Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.

  Trials 20100101

• Statin-associated weakness in myasthenia gravis: a case report.

  Journal of medical case reports 20100101

• A potential tocopherol acetate loaded palm oil esters-in-water nanoemulsions for nanocosmeceuticals.

  Journal of nanobiotechnology 20100101

• Allergic reaction related to ramipril use: a case report.

  Diabetology & metabolic syndrome 20100101

• Trends in publications regarding evidence-practice gaps: a literature review.

  Implementation science : IS 20100101

• Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients.

  Vascular health and risk management 20100101

• Could pre-diabetes be considered a clinical condition? opinions from an endocrinologist and a cardiologist.

  Diabetology & metabolic syndrome 20100101

• JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial.

  Trials 20100101

• Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine.

  Vascular health and risk management 20100101

• Endothelial progenitor cells: what use for the cardiologist?

  Journal of angiogenesis research 20100101

• Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

• Primary percutaneous coronary intervention for acute myocardial infarction in a young female with idiopathic thrombocytopenic purpura: a case report and review.

  Case reports in medicine 20100101

• Identification and determination of antihypertonics from the group of angiotensin-convertase inhibitors by densitometric method in comparition with HPLC method.

  Acta poloniae pharmaceutica 20100101

• Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.

  PloS one 20100101

• Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.

  PloS one 20100101

• Adrenal incidentaloma: a case of carcinoma.

  Clinical interventions in aging 20100101

• Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes.

  Vascular health and risk management 20100101

• Papillary thyroid cancer associated with syndrome of inappropriate antidiuresis: a case report.

  Journal of medical case reports 20100101

• Reversible dilated cardiomyopathy in a patient with Cushing's syndrome.

  Congestive heart failure (Greenwich, Conn.) 20100101

• The role of renin angiotensin system inhibition in kidney repair.

  Fibrogenesis & tissue repair 20100101

• New standards in hypertension and cardiovascular risk management: focus on telmisartan.

  Vascular health and risk management 20100101

• From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program.

  BMC medical informatics and decision making 20100101

• [Inappropriate antidiuretic hormone secretion syndrome associated with ramipril treatment].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101

• Forecasting drug utilization and expenditure in a metropolitan health region.

  BMC health services research 20100101

• Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy: a case report.

  Journal of medical case reports 20100101

• Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend.

  Acta clinica Belgica 20100101

• Testing for heterogeneity among the components of a binary composite outcome in a clinical trial.

  BMC medical research methodology 20100101

• Should we screen for masked hypertension in patient with vascular disease?

  Vascular health and risk management 20100101

• Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study.

  Indian journal of nephrology 20100101

• Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence.

  Vascular health and risk management 20100101

• [Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension].

  Lijecnicki vjesnik 20100101

• Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.

  American journal of nephrology 20100101

• Use of evidence-based pharmacotherapy after myocardial infarction in Estonia.

  BMC public health 20100101

• Combination therapy in hypertension: An update.

  Diabetology & metabolic syndrome 20100101

• Bleeding from ruptured hepatic metastases as a cause of syncope in an octogenarian: a case report.

  Journal of medical case reports 20100101

• RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form.

  Indian journal of pharmaceutical sciences 20100101

• Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy.

  Journal of neuroinflammation 20100101

• Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier.

  Journal of translational medicine 20100101

• PPARs in the Renal Regulation of Systemic Blood Pressure.

  PPAR research 20100101

• [Variability of cardiac rhythm in patients with a symptomatic renal hypertension and effect of ramipril on its changes].

  Likars'ka sprava 20100101

• Use of statin therapy to reduce cardiovascular risk in older patients.

  Current gerontology and geriatrics research 20100101

• Synthetic peptides as structural maquettes of Angiotensin-I converting enzyme catalytic sites.

  Bioinorganic chemistry and applications 20100101

• Urticarial vasculitis from simvastatin: what is the alternative drug?

  Dermatitis : contact, atopic, occupational, drug 20100101

• Impact of medical therapy on atheroma volume measured by different cardiovascular imaging modalities.

  Cardiology research and practice 20100101

• Effect of ramipril alone compared to ramipril with eplerenone on diabetic nephropathy in streptozocin-induced diabetic rats.

  Pharmacology 20100101

• Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.

  PloS one 20100101

• A hepatitis C-positive patient with new onset of nephrotic syndrome and systemic amyloidosis secondary to common variable immunodeficiency.

  Annals of Saudi medicine 20100101

• Treatment of specific macrovascular beds in patients with diabetes mellitus.

  Osteopathic medicine and primary care 20100101

• Advanced glycation end products, oxidative stress and diabetic nephropathy.

  Oxidative medicine and cellular longevity 20100101

• Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients.

  Renal failure 20100101

• A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease.

  Renal failure 20100101

• Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection.

  Vascular health and risk management 20100101

• Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination.

  Vascular health and risk management 20100101

• Anticoagulation after anterior myocardial infarction and the risk of stroke.

  PloS one 20100101

• Inferior ST-Elevation Myocardial Infarction Associated with Takotsubo Cardiomyopathy.

  Case reports in medicine 20100101

• Therapeutic Implications of PPARgamma in Cardiovascular Diseases.

  PPAR research 20100101

• Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.

  International journal of rheumatology 20100101

• Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.

  Cardiovascular diabetology 20100101

• Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications.

  PloS one 20100101

• Indian research: Focus on clozapine.

  Indian journal of psychiatry 20100101

• [Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches].

  Recenti progressi in medicina 20100101

• Optimal management of sarcopenia.

  Clinical interventions in aging 20100101

• Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems.

  PloS one 20100101

• Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment.

  Vascular health and risk management 20100101

• Role of olmesartan in combination therapy in blood pressure control and vascular function.

  Vascular health and risk management 20100101

• Aliskiren and valsartan combination therapy for the management of hypertension.

  Vascular health and risk management 20100101

• Integrin α2-deficient mice provide insights into specific functions of collagen receptors in the kidney.

  Fibrogenesis & tissue repair 20100101

• Multifocal severe coronary artery vasospasm mistaken for diffuse atherosclerosis: a case report.

  Case reports in medicine 20100101

• Transversus abdominis plane block for an emergency laparotomy in a high-risk, elderly patient.

  Indian journal of anaesthesia 20100101

• Fatal thyrocardiac event.

  Indian journal of anaesthesia 20100101

• Renal protection in diabetes: lessons from ONTARGET.

  Cardiovascular diabetology 20100101

• Ventricular septal defect in a child with Alport syndrome: a case report.

  BMC cardiovascular disorders 20100101

• Recent advances in the management of hypertension.

  F1000 medicine reports 20100101

• Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study.

  Vascular health and risk management 20100101

• New class of agents for treatment of hypertension: focus on direct renin inhibition.

  Vascular health and risk management 20100101

• Acute hepatocellular and cholestatic injury during therapy with hydrochlorothiazide - clinicohistopathologic findings: a case report.

  Journal of medical case reports 20100101

• Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial.

  PloS one 20100101

• Ramipril affects hydrogen sulfide generation in mouse liver and kidney.

  Folia biologica 20100101

• Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes.

  Clinical Medicine Insights. Cardiology 20100101

• Natriuretic Peptide system and cardiovascular disease.

  Heart views : the official journal of the Gulf Heart Association 20100101

• Hypertension, diabetes and overweight: looming legacies of the Biafran famine.

  PloS one 20100101

• Acute thrombotic occlusion of right coronary and left circumflex coronary arteries in a patient with antiphospholipid syndrome: successful stent implantation.

  Case reports in medicine 20100101

• Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials.

  BMJ (Clinical research ed.) 20100101

• From evidence to rationale: cardiovascular protection by angiotensin II receptor blockers compared with angiotensin-converting enzyme inhibitors.

  Cardiology 20100101

• Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

  Vascular health and risk management 20100101

• Population based screening for chronic kidney disease: cost effectiveness study.

  BMJ (Clinical research ed.) 20100101

• A defect in Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians.

  Lipids in health and disease 20100101

• Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study.

  Cardiovascular diabetology 20100101

• Angiotensin-converting enzyme inhibitors will help in improving stroke outcome if given immediately after stroke.

  Annals of Indian Academy of Neurology 20100101

• Angiotensin-converting enzyme inhibitors will not help in improving stroke outcome if given immediately after stroke.

  Annals of Indian Academy of Neurology 20100101

• Development of a duodenal gallstone ileus with gastric outlet obstruction (Bouveret syndrome) four months after successful treatment of symptomatic gallstone disease with cholecystitis and cholangitis: a case report.

  Journal of medical case reports 20100101

• [Possibilities of ramipril in primary and secondary prevention of cardiovascular diseases].

  Kardiologiia 20100101

• Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.

  BMJ (Clinical research ed.) 20100101

• Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes.

  PloS one 20100101

• Omalizumab: Practical considerations regarding the risk of anaphylaxis.

  Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20100101

• Simultaneous determination of atorvastatin calcium and ramipril in capsule dosage forms by high-performance liquid chromatography and high-performance thin layer chromatography.

  Journal of AOAC International 20100101

• Advanced Age, Female Gender and Delay in Pacemaker Implantation May Cause TdP in Patients With Complete Atrioventricular Block.

  Indian pacing and electrophysiology journal 20100101

• Exercised-induced coronary spasm in near normal coronary arteries.

  International journal of vascular medicine 20100101

• Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly.

  Clinical interventions in aging 20100101

• Where does the evidence lead us for the proper use of angiotensin II inhibitors in the management of cardiovascular disease?

  Cardiology 20100101

• ACE gene insertion/deletion polymorphism has a mild influence on the acute development of left ventricular dysfunction in patients with ST elevation myocardial infarction treated with primary PCI.

  BMC cardiovascular disorders 20100101

• Treatment of dyslipidemia in patients with type 2 diabetes.

  Lipids in health and disease 20100101

• Simultaneous quantitative determination of metoprolol, atorvastatin and ramipril in capsules by a validated stability-indicating RP-UPLC method.

  Scientia pharmaceutica 20100101

• Beta blockers & left ventricular hypertrophy regression.

  Indian heart journal 20100101

• Cardio classics revisited--focus on the role of candesartan.

  Vascular health and risk management 20100101

• In a subgroup of high-risk Asians, telmisartan was non-inferior to ramipril and better tolerated in the prevention of cardiovascular events.

  PloS one 20100101

• Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: a case report.

  Case reports in medicine 20100101

• Guillain-barré syndrome after thrombolysis with streptokinase.

  Cardiology research and practice 20100101

• Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

  Experimental diabetes research 20100101

• Experimental models of renal disease and the cardiovascular system.

  The open cardiovascular medicine journal 20100101

• Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk.

  International journal of hypertension 20100101

• A pharmacovigilance study in medicine department of tertiary care hospital in chhattisgarh (jagdalpur), India.

  Journal of young pharmacists : JYP 20100101

• Effect of PPARγ inhibition during pregnancy on posterior cerebral artery function and structure.

  Frontiers in physiology 20100101

• Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20100101

• [Efficacy of ramipril, carvedilol, and trimetazidine MR in improvement of quality of life of patients after myocardial infarction].

  Kardiologiia 20100101

• Renovascular and renoprotective properties of telmisartan: clinical utility.

  International journal of nephrology and renovascular disease 20100101

• Uncontrolled hypertension secondary to leukemic cell infiltration of kidneys in a hemodialysis patient.

  International journal of nephrology and renovascular disease 20100101

• Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy.

  Drug, healthcare and patient safety 20100101

• Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers.

  Drug, healthcare and patient safety 20100101

• [Efficacy of complex therapy with metformin and ramipril combination for patients with metabolic syndrome].

  Likars'ka sprava 20100101

• Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility.

  Integrated blood pressure control 20100101

• Evidence-based approach for managing hypertension in type 2 diabetes.

  Integrated blood pressure control 20100101

• Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction.

  Integrated blood pressure control 20100101

• Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill.

  Integrated blood pressure control 20100101

• Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals.

  Integrated blood pressure control 20100101

• Impact of telmisartan in modifying vascular risk.

  Integrated blood pressure control 20100101

• Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals.

  Integrated blood pressure control 20100101

• Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control.

  Integrated blood pressure control 20100101

• Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination.

  Integrated blood pressure control 20100101

• First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination.

  Integrated blood pressure control 20100101

• Cardiovascular risk reduction with Renin-Angiotensin aldosterone system blockade.

  Nursing research and practice 20100101

• [New drugs for small animals in 2009].

  Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 20100101

• Hptlc method development and validation of trandolapril in bulk and pharmaceutical dosage forms.

  Journal of advanced pharmaceutical technology & research 20100101

• Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer treatment and/or higher doses?

  Clinical pharmacology : advances and applications 20100101

• Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia/reperfusion injury in normotensive rat.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

• Kidney disease in nail-patella syndrome.

  Pediatric nephrology (Berlin, Germany) 20091201

• Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics.

  European journal of pediatrics 20091201

• Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20091201

• Telmisartan prevents cardiovascular events in a broad group of at-risk patients.

  Expert opinion on pharmacotherapy 20091201

• Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).

  The American journal of cardiology 20091201

• Projecting the future diabetes population size and related costs for the U.S.

  Diabetes care 20091201

• Effect of Labrasol on self-nanoemulsification efficiency of ramipril nanoemulsion.

  Die Pharmazie 20091201

• Biochemical effects of irbesartan in experimental diabetic nephropathy.

  Indian journal of pharmacology 20091201

• Mmp-9, a potential target for cerebral ischemic treatment.

  Current neuropharmacology 20091201

• Myotonic dystrophy: an anaesthetic dilemma.

  Indian journal of anaesthesia 20091201

• Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition.

  Clinical science (London, England : 1979) 20091116

• Renal transplant donation from a deceased cardiac graft recipient: a case for marginal donors.

  Pediatric transplantation 20091101

• Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20091101

• Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

  Diabetes 20091101

• Decreased renal perfusion rapidly increases plasma membrane Na-K-ATPase in rat cortex by an angiotensin II-dependent mechanism.

  American journal of physiology. Renal physiology 20091101

• Bioanalytical method development and validation using incurred samples--simultaneous quantitation of ramipril and ramiprilat in human EDTA plasma by LC-MS/MS.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091101

• Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy.

  Diabetes care 20091101

• How to define prehypertension in diabetes/metabolic syndrome.

  Diabetes care 20091101

• Should we treat prehypertension in diabetes? What are the cons?

  Diabetes care 20091101

• Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros?

  Diabetes care 20091101

• Hypertension and diabetes: should we treat early surrogates? What are the cons?

  Diabetes care 20091101

• Glucose control and cardiovascular disease: is it important? No.

  Diabetes care 20091101

• Dual blockade of the renin-angiotensin system in diabetic nephropathy.

  Diabetes care 20091101

• Role of angiotensin receptor blockers in diabetes: implications of recent clinical trials.

  Expert review of cardiovascular therapy 20091101

• [Role of ACE-inhibitors in preventing atrial fibrillation relapses in normotensive patients].

  Recenti progressi in medicina 20091101

• Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review.

  Current cardiology reviews 20091101

• [Cardioprotection of ramipril and BQ-123 against myocardial ischemia/reperfusion injury in vivo in rats].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20091101

• [Study on ultrastructure of cardioprotection of ramipril against ischemia/reperfusion injury in diabetic rats].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20091101

• Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.

  Clinical science (London, England : 1979) 20091026

• Strict blood-pressure control and progression of renal failure in children.

  The New England journal of medicine 20091022

• Blood-pressure control and delay in progression of kidney disease in children.

  The New England journal of medicine 20091022

• Treatment of hypertension in peripheral arterial disease.

  The Cochrane database of systematic reviews 20091007

• Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.

  Circulation 20091006

• Treatment of hypertension in children and adolescents.

  Pediatric nephrology (Berlin, Germany) 20091001

• Familial hematuria.

  Pediatric nephrology (Berlin, Germany) 20091001

• Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.

  Diabetes care 20091001

• Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).

  Diabetes care 20091001

• Physicians' view of primary care-based case management for patients with heart failure: a qualitative study.

  International journal for quality in health care : journal of the International Society for Quality in Health Care 20091001

• Dual renin-angiotensin system blockade in the ONTARGET study: clinically relevant risk for the kidney?

  Current hypertension reports 20091001

• [Renin-angiotensin-aldosterone system inhibition and cardiovascular protection].

  Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20091001

• [The future of renin inhibition].

  Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20091001

• Role of renin-angiotensin system blockade in patients with diabetes mellitus.

  The American journal of cardiology 20090915

• Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials.

  Journal of human hypertension 20090901

• Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.

  Diabetes 20090901

• Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively.

  American journal of hypertension 20090901

• Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20090901

• Severe paradoxical hypertension with angiotensin-converting enzyme inhibitors: an unusual feature of renal artery stenosis.

  Hypertension (Dallas, Tex. : 1979) 20090901

• Lessons learned from the ONTARGET and TRANSCEND trials.

  Current atherosclerosis reports 20090901

• Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.

  Pharmacogenetics and genomics 20090901

• Autosomal dominant polycystic kidney disease: 2009 update for internists.

  The Korean journal of internal medicine 20090901

• Aliskiren corrects recurrent hyperreninemia and hyperaldosteronism in autosomal dominant polycystic kidney disease.

  Clinical nephrology 20090901

• Investigation of effects of Lacidipine, Ramipril and Valsartan on DNA damage and oxidative stress occurred in acute and chronic periods following isoproterenol-induced myocardial infarct in rats.

  Molecular and cellular biochemistry 20090801

• Superior consistency of ambulatory blood pressure monitoring in children: implications for clinical trials.

  Journal of hypertension 20090801

• Advances in the medical treatment of diabetic retinopathy.

  Diabetes care 20090801

• Primary prevention of type 2 diabetes: there are no simple solutions!

  Diabetes 20090801

• Proteinuria: Is the ONTARGET renal substudy actually off target?

  Nature reviews. Nephrology 20090801

• Diminished renal function and the incidence of heart failure.

  Current cardiology reviews 20090801

• Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model.

  Circulation 20090728

• Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090701

• The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.

  Journal of cardiovascular electrophysiology 20090701

• The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.

  Clinical research in cardiology : official journal of the German Cardiac Society 20090701

• ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload.

  Cardiovascular research 20090701

• Spontaneous recanalization of a completely occluded saphenous vein graft two months following acute myocardial infarction with persistent one year patency.

  Journal of thrombosis and thrombolysis 20090701

• Does it matter when drugs are taken?

  Hypertension (Dallas, Tex. : 1979) 20090701

• Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing.

  Hypertension (Dallas, Tex. : 1979) 20090701

• The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.

  Acta pharmacologica Sinica 20090701

• Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.

  Journal of hypertension 20090701

• Effect of angiotensin-converting enzyme inhibition on C-reactive protein levels: the ramipril C-reactive pRotein randomized evaluation (4R) trial results.

  The Canadian journal of cardiology 20090701

• Introduction: Reducing cardiovascular risk: ONTARGET--a new standard in cardiovascular protection.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090701

• Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090701

• Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090701

• Cardiovascular protection: a breakthrough for high-risk patients?

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090701

• Achieving blood pressure goals: should angiotensin II receptor blockers become first-line treatment in hypertension?

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090701

• Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts.

  PLoS computational biology 20090701

• Angiotensin-converting enzyme is a modifier of hypertensive end organ damage.

  The Journal of biological chemistry 20090605

• Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).

  Journal of the American College of Cardiology 20090602

• STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone): is the biggest big enough?

  Journal of the American College of Cardiology 20090602

• Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibition.

  The Journal of pharmacology and experimental therapeutics 20090601

• Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension.

  American journal of hypertension 20090601

• Hotline sessions presented at the American College of Cardiology Congress 2009.

  Clinical research in cardiology : official journal of the German Cardiac Society 20090601

• Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome.

  The American journal of cardiology 20090601

• Cardiac sympathetic activity in stress-induced (Takotsubo) cardiomyopathy.

  Nature reviews. Cardiology 20090601

• ONTARGET: use of ramipril, telmisartan, or both in patients with high cardiovascular risks.

  Current diabetes reports 20090601

• How to achieve renal protection in the light of ONTARGET?

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090601

• Practical aspects of treatment discontinuation and adherence.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090601

• The question of heart failure in ONTARGET and TRANSCEND: implications for clinical practice.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090601

• Implementation of new evidence into hypertension guidelines: the case of the ONTARGET and TRANSCEND trials.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090601

• Focus on the ONTARGET results.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20090601

• Blocking the renin-angiotensin system: dual- versus mono-therapy.

  Expert review of cardiovascular therapy 20090601

• Established and newly proposed mechanisms of chronic cyclosporine nephropathy.

  The Korean journal of internal medicine 20090601

• Acute subdural hematoma following spinal cerebrospinal fluid drainage in a patient with freezing of gait.

  Journal of clinical neurology (Seoul, Korea) 20090601

• Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.

  Lancet (London, England) 20090523

• Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.

  Journal of human hypertension 20090501

• Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome.

  Diabetes care 20090501

• Diabetic cardiomyopathy.

  Clinical science (London, England : 1979) 20090501

• CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.

  Vnitrni lekarstvi 20090501

• Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.

  Clinical therapeutics 20090501

• The effect of telmisartan on endothelial function and arterial stiffness in patients with essential hypertension.

  Korean circulation journal 20090501

• Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.

  Lancet (London, England) 20090418

• Antihypertensive therapy, new-onset diabetes, and cardiovascular disease.

  International journal of clinical practice 20090401

• Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

  Diabetes 20090401

• Clinical practice guides.

  Clinical cardiology 20090401

• Cardiomyopathy presenting as severe fatigue in a person with chronic spinal cord injury.

  The journal of spinal cord medicine 20090401

• Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials.

  Lancet (London, England) 20090321

• Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring.

  British journal of cancer 20090310

• Long-term outcome of chronic dialysis in children.

  Pediatric nephrology (Berlin, Germany) 20090301

• The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice.

  Experimental physiology 20090301

• Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET--a call for more circumspection.

  QJM : monthly journal of the Association of Physicians 20090301

• Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.

  Molecular pharmacology 20090301

• Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.

  Diabetes research and clinical practice 20090301

• Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.

  Clinical journal of the American Society of Nephrology : CJASN 20090301

• Cost analysis of iron-related complications in a single institute.

  The Korean journal of internal medicine 20090301

• Review: renal protection by inhibition of the renin-angiotensin-aldosterone system.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20090301

• Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and renal outcomes in nephropathy?

  Postgraduate medicine 20090301

• Review of ONTARGET: treating patients at high risk for vascular events with telmisartan, ramipril, or both. Commentary.

  Postgraduate medicine 20090301

• Tako-tsubo cardiomyopathy observed in a patient with sepsis and transient hyperthyroidism.

  Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 20090301

• Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.

  Journal of the Indian Medical Association 20090301

• [Renal effect of treatment for heart failure].

  Ugeskrift for laeger 20090223

• The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point.

  Journal of the American College of Cardiology 20090210

• Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20090201

• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study.

  Nature clinical practice. Cardiovascular medicine 20090201

• ONTARGET: How much RAS inhibition is enough?

  Current hypertension reports 20090201

• Topics in type 2 diabetes and insulin resistance.

  Diabetes care 20090201

• A combination of telmisartan and ramipril increased renal outcomes in vascular disease or diabetes.

  Evidence-based medicine 20090201

• Effects of aggressive approach to the multiple risk factors for diabetic nephro-pathy on proteinuria reduction in diabetes type 2 patients.

  Bosnian journal of basic medical sciences 20090201

• [The ONTARGET trial].

  Giornale italiano di cardiologia (2006) 20090201

• Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

  Journal of the American College of Cardiology 20090106

• Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090101

• Increased aldosterone levels in a model of type 2 diabetes mellitus.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20090101

• Re-examining RAS-blocking treatment regimens for abrogating progression of chronic kidney disease.

  Nature clinical practice. Nephrology 20090101

• Hypertension-mediated albuminuria is associated with reduced lysosomal activity in the kidney and the heart.

  American journal of nephrology 20090101

• Normal pregnancy and healthy child after continued exposure to gliclazide and ramipril during pregnancy.

  The Annals of pharmacotherapy 20090101

• Standards of medical care in diabetes--2009.

  Diabetes care 20090101

• Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis.

  PloS one 20090101

• How 40 kilograms of fluid retention can be overlooked: two case reports.

  Cases journal 20090101

• Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches.

  BMC research notes 20090101

• Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings.

  BMJ (Clinical research ed.) 20090101

• ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?

  Blood pressure 20090101

• N-terminal pro-brain natriuretic peptide levels predict left ventricular systolic function in patients with chronic kidney disease.

  Journal of Korean medical science 20090101

• The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography.

  Journal of Korean medical science 20090101

• Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

  PloS one 20090101

• ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.

  BMC cardiovascular disorders 20090101

• From Tritace to Tri-Plen - the South African journey.

  Cardiovascular journal of Africa 20090101

• Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk.

  Preventive cardiology 20090101

• Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine.

  Annals of Saudi medicine 20090101

• Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [Nalpha-Bodipy]-des-Arg9-bradykinin.

  Journal of neuroinflammation 20090101

• Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus.

  BMC nephrology 20090101

• Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review.

  Cardiovascular diabetology 20090101

• The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.

  Mediators of inflammation 20090101

• Recent advances in cardiovascular risk reduction: implications of ONTARGET.

  Clinical cornerstone 20090101

• Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective.

  Cost effectiveness and resource allocation : C/E 20090101

• Long-term survival of chronic dialysis patients following survival from an episode of multiple-organ failure.

  Critical care (London, England) 20090101

• DreamTel; Diabetes risk evaluation and management tele-monitoring study protocol.

  BMC endocrine disorders 20090101

• The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

  BMC public health 20090101

• Candesartan cilexetil in the treatment of chronic heart failure.

  Vascular health and risk management 20090101

• Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptors.

  Vascular health and risk management 20090101

• Results of the ONTARGET and TRANSCEND studies: an update and discussion.

  Vascular health and risk management 20090101

• Redefining the role of thiazolidinediones in the management of type 2 diabetes.

  Vascular health and risk management 20090101

• The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man.

  Vascular health and risk management 20090101

• Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study.

  Vascular health and risk management 20090101

• Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.

  Vascular health and risk management 20090101

• Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.

  Vascular health and risk management 20090101

• Clopidogrel resistance 'Live' - the risk of stent thrombosis should be evaluated before procedures.

  Thrombosis journal 20090101

• [The study of effects of ramipril and amlodipine combination in patients with arterial hypertension and type 2 diabetes mellitus].

  Kardiologiia 20090101

• Prevention of diabetes in hypertensive patients: results and implications from the VALUE trial.

  Vascular health and risk management 20090101

• Safety and efficacy of rosiglitazone in the elderly diabetic patient.

  Vascular health and risk management 20090101

• Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.

  Vascular health and risk management 20090101

• Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension.

  Vascular health and risk management 20090101

• Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.

  Vascular health and risk management 20090101

• Impact of statins and ACE inhibitors on mortality after COPD exacerbations.

  Respiratory research 20090101

• Making trials matter: pragmatic and explanatory trials and the problem of applicability.

  Trials 20090101

• Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension.

  Clinical interventions in aging 20090101

• Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study.

  AIDS research and therapy 20090101

• Emergency management of decompensated peripartum cardiomyopathy.

  Journal of emergencies, trauma, and shock 20090101

• Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.

  PloS one 20090101

• Analytical review of the evidence for renoprotection by renin-angiotensin-aldosterone system blockade in chronic kidney disease - a call for caution.

  Nephron. Clinical practice 20090101

• High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo.

  BMC nephrology 20090101

• Effect of rosiglitazone on progression of atherosclerosis: insights using 3D carotid cardiovascular magnetic resonance.

  Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20090101

• Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension.

  Vascular health and risk management 20090101

• PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial.

  BMC research notes 20090101

• A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.

  Vascular health and risk management 20090101

• Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?

  PPAR research 20090101

• Need for new hypertension guidelines for high-risk patients.

  Cardiovascular journal of Africa 20090101

• Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.

  Therapeutics and clinical risk management 20090101

• A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.

  Therapeutics and clinical risk management 20090101

• Truths and Lies from the Polysomnography ECG Recording: An Electrophysiologist Perspective.

  Case reports in medicine 20090101

• Quality and stability of ramipril generics/copies versus reference ramipril (Tritace): a 3-month stability comparative study.

  Clinical drug investigation 20090101

• Cardiovascular disease in patients with chronic kidney disease.

  Vascular health and risk management 20090101

• Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study.

  BMC nephrology 20090101

• Antiatherogenic effects of vitamin E: the search for the Holy Grail.

  Vascular health and risk management 20090101

• Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation.

  Vascular health and risk management 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Bioequivalence study of two tablet formulations of ramipril in healthy volunteers.

  Arzneimittel-Forschung 20090101

• Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study.

  BMC nephrology 20090101

• Diabetic nephropathy.

  Diabetology & metabolic syndrome 20090101

• Patient risk factors and adverse drug interactions in the treatment of acute gouty arthritis in the elderly: a case report.

  Cases journal 20090101

• Hypokalaemia and cardiac arrest complicating vancomycin and furosemide therapy: a case report.

  Cases journal 20090101

• The treatment of hypertension with telmisartan in the sphere of circadian rhythm in metabolic syndrome in the elderly.

  Archives of gerontology and geriatrics 20090101

• Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis.

  International archives of medicine 20090101

• Late thrombosis of sirolimus-eluting stent: a multifactorial problem.

  Case reports in medicine 20090101

• A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency.

  Case reports in medicine 20090101

• Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?

  Journal of the American Board of Family Medicine : JABFM 20090101

• Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.

  Vascular health and risk management 20090101

• Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.

  Vascular health and risk management 20090101

• Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles.

  Arthritis research & therapy 20090101

• Development of a patient decision aid for prevention of myocardial infarction in type 2 diabetes - rationale, design and pilot testing.

  Psycho-social medicine 20090101

• Acute stent thrombosis in a sirolimus eluting stent after wasp sting causing acute myocardial infarction: a case report.

  Cases journal 20090101

• Coronary artery disease mimicking Tako-tsubo cardiomyopathy: a case report.

  Cases journal 20090101

• Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food.

  Current pharmaceutical design 20090101

• A randomized trial comparing the effect of ramipril and losartan in survivors of ST-elevation myocardial infarction.

  The Journal of international medical research 20090101

• Inflammatory bowel disease, such as Ulcerative colitis, is a risk factor for recurrent thromboembolic events: a case report.

  Cases journal 20090101

• A patient presenting with symptomatic hypomagnesemia caused by metformin-induced diarrhoea: a case report.

  Cases journal 20090101

• Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

  BMJ (Clinical research ed.) 20090101

• Review of the treatment of acute coronary syndrome in elderly patients.

  Clinical interventions in aging 20090101

• Myocarditis mimicking an acute coronary syndrome: a case related to Salmonella enteritis.

  Gastroenterology research and practice 20090101

• Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.

  Vascular health and risk management 20090101

• Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence.

  Vascular health and risk management 20090101

• Comparative assessment of angiotensin receptor blockers in different clinical settings.

  Vascular health and risk management 20090101

• Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study.

  BMC family practice 20090101

• Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients.

  Molecular vision 20090101

• An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation.

  Journal of medical Internet research 20090101

• An unusual case of an obtuse marginal branch supplying the left ventricular apex.

  Cardiovascular journal of Africa 20090101

• Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension.

  Respiratory research 20090101

• Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report.

  Cases journal 20090101

• Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.

  Journal of medical case reports 20090101

• The right ventricle: biologic insights and response to disease.

  Current cardiology reviews 20090101

• Management of asymptomatic severe aortic stenosis.

  Current cardiology reviews 20090101

• Preparation, characterization, and analytical application of ramipril membrane-based ion-selective electrode.

  International journal of analytical chemistry 20090101

• Telmisartan: a different angiotensin II receptor blocker protecting a different population?

  The Journal of international medical research 20090101

• Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

  International journal of diabetes in developing countries 20090101

• Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion.

  Case reports in medicine 20090101

• RP-HPLC Estimation of Ramipril and Telmisartan in Tablets.

  Indian journal of pharmaceutical sciences 20090101

• A pharmacovigilance study of antihypertensive medicines at a South delhi hospital.

  Indian journal of pharmaceutical sciences 20090101

• Stabilization of quinapril by incorporating hydrogen bonding interactions.

  Indian journal of pharmaceutical sciences 20090101

• Simultaneous estimation of amlodipine besilate and olmesartan medoxomil in pharmaceutical dosage form.

  Indian journal of pharmaceutical sciences 20090101

• Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact.

  Core evidence 20090101

• Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats.

  Oxidative medicine and cellular longevity 20090101

• Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease.

  F1000 medicine reports 20090101

• Prevention of dementia: Role of vascular risk factors and cerebral emboli.

  Indian journal of psychiatry 20090101

• Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20090101

• Severe hyponatraemia during therapy with ramipril.

  BMJ case reports 20090101

• Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials.

  Integrated blood pressure control 20090101

• Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility.

  Integrated blood pressure control 20090101

• Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors.

  Integrated blood pressure control 20090101

• Clinical approach in treatment of resistant hypertension.

  Integrated blood pressure control 20090101

• A combination of telmisartan and ramipril increased renal outcomes in vascular disease or diabetes.

  ACP journal club 20081216

• Value of urinary albumin-to-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals.

  Diabetes care 20081201

• Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry.

  Diabetes care 20081201

• Proteinuria lowering needs a multifactorial and individualized approach to halt progression of renal disease.

  Nature clinical practice. Nephrology 20081201

• Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.

  The journal of physiological sciences : JPS 20081201

• Enhanced stability of ramipril in nanoemulsion containing cremophor-EL: a technical note.

  AAPS PharmSciTech 20081201

• Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.

  American journal of hypertension 20081201

• Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.

  Journal of hypertension 20081201

• Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.

  Blood pressure. Supplement 20081201

• Update on the use of trandolapril in the management of cardiovascular disorders.

  Vascular health and risk management 20081201

• Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine.

  Vascular health and risk management 20081201

• Peripheral artery disease: potential role of ACE-inhibitor therapy.

  Vascular health and risk management 20081201

• Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.

  Vascular health and risk management 20081201

• Long-acting nifedipine in the management of the hypertensive patient.

  Vascular health and risk management 20081201

• The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target.

  Vascular health and risk management 20081201

• Vildagliptin: a new oral treatment for type 2 diabetes mellitus.

  Vascular health and risk management 20081201

• Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease.

  Biologics : targets & therapy 20081201

• Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

  Journal of medicinal chemistry 20081113

• Letter by Popa and Netea regarding article, 'Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis'.

  Circulation 20081104

• Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.

  The Journal of pharmacology and experimental therapeutics 20081101

• Magnitude of the early morning blood pressure surge in untreated hypertensive patients: a pooled analysis.

  International journal of clinical practice 20081101

• American College of Endocrinology Pre-Diabetes Consensus Conference: part two.

  Diabetes care 20081101

• Spectrophotometric and atomic absorption determination of ramipril, enalapril maleate and fosinopril through ternary complex formation with molybdenum (V)-thiocyanate (Mo(V)-SCN).

  Chemical & pharmaceutical bulletin 20081101

• Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats.

  Canadian journal of physiology and pharmacology 20081101

• Reduced cortical renal GLUT1 expression induced by angiotensin-converting enzyme inhibition in diabetic spontaneously hypertensive rats.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20081101

• Regulation of oxidative stress and cardioprotection in diabetes mellitus.

  Current cardiology reviews 20081101

• Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress.

  Current cardiology reviews 20081101

• The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.

  Current cardiology reviews 20081101

• Telmisartan, ramipril, or both in patients at high risk for vascular events.

  Current hypertension reports 20081001

• ONTARGET Study of Telmisartan, Ramipril, or Both in High-Risk Patients.

  Current hypertension reports 20081001

• Inhibiting angiotensin type 1 receptors as a target for diabetes.

  Expert opinion on therapeutic targets 20081001

• Enalapril and captopril increased mortality compared with ramipril in elderly patients with heart failure.

  Evidence-based nursing 20081001

• Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies: response to Hadjadj et al.

  Diabetes care 20081001

• American College Of Endocrinology Pre-Diabetes Consensus Conference: part one.

  Diabetes care 20081001

• Telmisartan and ramipril were equivalent, but their combination increased adverse events in vascular disease or diabetes.

  Evidence-based medicine 20081001

• The relationship between proteinuria and coronary risk: a systematic review and meta-analysis.

  PLoS medicine 20081001

• [Effects of ramipril and simvastatin on the oxidative stress of diabetic rats].

  Arquivos brasileiros de endocrinologia e metabologia 20081001

• The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.

  Vascular health and risk management 20081001

• Nephrotic range proteinuria in c-ANCA-positive crescentic glomerulonephritis with linear immune deposits.

  Indian journal of nephrology 20081001

• Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study.

  International journal of cardiology 20080926

• Trials and tribulations in adult congenital heart disease.

  International journal of cardiology 20080926

• [ONTARGET, PROFESS, TRANSCEND large scale studies. AT1 blockers: evidence based advantage, but less than expected].

  MMW Fortschritte der Medizin 20080918

• Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study.

  Diabetes care 20080901

• Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.

  Diabetes care 20080901

• Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.

  American journal of hypertension 20080901

• Dilated cardiomyopathy: an unusual complication of clozapine therapy.

  Nature clinical practice. Cardiovascular medicine 20080901

• Does the angiotensin receptor blocker telmisartan prevent morbid atherosclerotic events?

  Nature clinical practice. Cardiovascular medicine 20080901

• [ Therapy of patients at high risk for vascular events: telmisartan, ramipril or a combination? ].

  Der Internist 20080901

• An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.

  Clinical therapeutics 20080901

• The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080901

• Can aliskiren reduce the incidence of cough caused by ramipril?

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20080901

• [What is the purpose of dual or triple inhibition of the renin-angiotensin-aldosterone system?].

  Revue medicale suisse 20080827

• Renin-angiotensin blockade and kidney disease.

  Lancet (London, England) 20080816

• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

  Lancet (London, England) 20080816

• [A 60-year-old man with heart failure, dry cough and elevated INR values].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080814

• Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice.

  Atherosclerosis 20080801

• Stages of motor output reorganization after hemispheric stroke suggested by longitudinal studies of cortical physiology.

  Cerebral cortex (New York, N.Y. : 1991) 20080801

• Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy.

  Pediatric nephrology (Berlin, Germany) 20080801

• Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).

  Diabetes care 20080801

• Dysglycemia and a history of reproductive risk factors.

  Diabetes care 20080801

• Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.

  Journal of human hypertension 20080801

• Late treatment with angiotensin-converting enzyme inhibitors plus endothelin receptor antagonists ameliorates rat tracheal allograft rejection.

  Transplant international : official journal of the European Society for Organ Transplantation 20080801

• Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080801

• A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit.

  European journal of heart failure 20080801

• Do ACE inhibitors all provide the same outcomes benefits in high-risk cardiovascular patients?

  Current hypertension reports 20080801

• Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.

  Journal of veterinary pharmacology and therapeutics 20080801

• Approaches to treatment of type 2 diabetes.

  Diabetes care 20080801

• The renin-angiotensin system and diabetes: an update.

  Vascular health and risk management 20080801

• Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.

  Vascular health and risk management 20080801

• ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.

  Therapeutic advances in cardiovascular disease 20080801

• Fatal metformin overdose presenting with progressive hyperglycemia.

  The western journal of emergency medicine 20080801

• Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention.

  Current cardiology reviews 20080801

• Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance.

  European journal of pharmacology 20080728

• Telmisartan, ramipril, or both in patients at high risk of vascular events.

  The New England journal of medicine 20080724

• Telmisartan, ramipril, or both in patients at high risk of vascular events.

  The New England journal of medicine 20080724

• Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes.

  Diabetes, obesity & metabolism 20080701

• [Acute renal insufficiency after flurbiprofen treatment in a patient treated with angiotensin converting enzyme inhibitor].

  La Revue de medecine interne 20080701

• Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease.

  Pediatric nephrology (Berlin, Germany) 20080701

• Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function.

  International journal of clinical practice 20080701

• The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.

  Journal of hypertension 20080701

• A new dawn in cardiovascular protection: total cardiovascular risk: rigorous treatment of risk factors. Introduction.

  Nature clinical practice. Cardiovascular medicine 20080701

• Beyond the classic angiotensin-receptor-blocker profile.

  Nature clinical practice. Cardiovascular medicine 20080701

• Approaches to treatment of pre-diabetes and obesity and promising new approaches to type 2 diabetes.

  Diabetes care 20080701

• Simultaneous estimation of atorvastatin and ramipril by RP-HPLC and spectroscopy.

  Pakistan journal of pharmaceutical sciences 20080701

• Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.

  Journal of the Indian Medical Association 20080701

• [No advantage of the combination of ACE-inhibition and angiotensin receptor blockade in patients with high cardiovascular risk].

  Nederlands tijdschrift voor geneeskunde 20080614

• Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia.

  Pharmacoepidemiology and drug safety 20080601

• Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.

  The Journal of pharmacology and experimental therapeutics 20080601

• Direct renin inhibition: clinical pharmacology.

  Journal of molecular medicine (Berlin, Germany) 20080601

• Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.

  Pediatric nephrology (Berlin, Germany) 20080601

• Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.

  Expert review of cardiovascular therapy 20080601

• [Choroidal effusion after uncomplicated cataract surgery].

  Klinische Monatsblatter fur Augenheilkunde 20080601

• ONTARGET: questions asked, questions answered.

  Journal of clinical hypertension (Greenwich, Conn.) 20080601

• Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena.

  COPD 20080601

• Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20080601

• Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model.

  Biological chemistry 20080601

• Effect of Shenqi Compound Formula on PPARgamma in white adipose tissue of rats with macrovascular lesion in early stage of diabetes.

  Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 20080601

• [Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59].

  Kardiologia polska 20080601

• Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet.

  Vascular health and risk management 20080601

• Early vascular aging (EVA): consequences and prevention.

  Vascular health and risk management 20080601

• Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.

  Vascular health and risk management 20080601

• Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.

  Vascular health and risk management 20080601

• Spontaneous compartment syndrome in a patient with diabetes and statin administration: a case report.

  Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20080601

• [Treatment of patients at high cardiovascular risk: confirmation and surprising results of the ONTARGET-Study].

  Praxis 20080514

• Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080506

• Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace?

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080506

• Onset and enhancement of systemic sclerosis after treatments for multiple sclerosis.

  Rheumatology international 20080501

• The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction.

  Heart (British Cardiac Society) 20080501

• Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression.

  Experimental physiology 20080501

• Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

  Diabetes care 20080501

• Therapeutic strategies to slow chronic kidney disease progression.

  Pediatric nephrology (Berlin, Germany) 20080501

• Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk.

  International journal of clinical practice 20080501

• Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model.

  American journal of physiology. Renal physiology 20080501

• Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients.

  Journal of hypertension 20080501

• Peritubular capillary loss is ameliorated by ramipril or valsartan treatment.

  Microcirculation (New York, N.Y. : 1994) 20080501

• [New studies on hypertension of great significance to clinical practice. Also very old persons benefit from blood pressure reduction].

  Lakartidningen 20080501

• [Clinical study on Shen Shuai Fang in treating chronic renal failure].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20080501

• Critical review of the ankle brachial index.

  Current cardiology reviews 20080501

• Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.

  Circulation 20080429

• Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

  Archives of internal medicine 20080428

• [What is better here: ACE inhibitor or AT1 blocker?].

  MMW Fortschritte der Medizin 20080417

• Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats.

  Biochemical and biophysical research communications 20080411

• Telmisartan, ramipril, or both in patients at high risk for vascular events.

  The New England journal of medicine 20080410

• ACE inhibitors in cardiovascular disease--unbeatable?

  The New England journal of medicine 20080410

• Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.

  Life sciences 20080409

• The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.

  Diabetes 20080401

• Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction.

  American journal of physiology. Heart and circulatory physiology 20080401

• Renin inhibition with aliskiren.

  Clinical and experimental pharmacology & physiology 20080401

• Postoperative treatment with angiotensin-converting enzyme inhibitors in patients with preoperative reduced left ventricular systolic function.

  Journal of cardiothoracic and vascular anesthesia 20080401

• Determining the cost-effectiveness of preventing cardiovascular disease: are estimates calculated over the duration of a clinical trial adequate?

  The Canadian journal of cardiology 20080401

• Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes.

  Current atherosclerosis reports 20080401

• Orlistat in the prevention of diabetes in the obese patient.

  Vascular health and risk management 20080401

• Vascular risk factors, cognitive decline, and dementia.

  Vascular health and risk management 20080401

• Effect of ramipril on renal function in patients with intermittent claudication.

  Vascular health and risk management 20080401

• [ONTARGET: similar protection of telmisartan and ramipril and lack of benefit of combined therapy in patients at high risk for vascular events].

  Revue medicale de Liege 20080401

• [The effectiveness in type 2 diabetes prevention: a forced landing to reality].

  Medicina clinica 20080308

• Hypertension in children with chronic kidney disease: pathophysiology and management.

  Pediatric nephrology (Berlin, Germany) 20080301

• Identification of severe potential drug-drug interactions using an Italian general-practitioner database.

  European journal of clinical pharmacology 20080301

• Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease.

  Muscle & nerve 20080301

• Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.

  Journal of hypertension 20080301

• Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.

  Journal of hypertension 20080301

• Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation.

  The Annals of pharmacotherapy 20080301

• [Pace-maker syndrome].

  Deutsche medizinische Wochenschrift (1946) 20080301

• Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20080301

• Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice.

  Indian journal of experimental biology 20080301

• Carvedilol in the treatment of elderly patients with chronic heart failure.

  Clinical interventions in aging 20080301

• Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.

  Journal of the Indian Medical Association 20080301

• Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta: a randomized cross-over study.

  Journal of the American College of Cardiology 20080219

• Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction.

  British journal of clinical pharmacology 20080201

• Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080201

• Ramipril protects from free radical induced white matter damage in chronic hypoperfusion in the rat.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20080201

• Use of recommended medications after myocardial infarction in Austria.

  European journal of epidemiology 20080201

• Renal and cardiac effects of antihypertensive treatment with ramipril versus metoprolol in autosomal dominant polycystic kidney disease.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080201

• Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.

  American journal of hypertension 20080201

• Conversion of discoid lupus to antiphospholipid syndrome and SLE.

  Nature clinical practice. Rheumatology 20080201

• Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.

  Cardiology clinics 20080201

• The ADVANCE trial.

  Lancet (London, England) 20080105

• The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080101

• Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.

  Diabetes care 20080101

• Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.

  Journal of clinical pharmacology 20080101

• Interventricular septum hematoma during cineventriculography.

  Cardiovascular ultrasound 20080101

• Drivers for change in primary care of diabetes following a protected learning time educational event: interview study of practitioners.

  BMC medical education 20080101

• The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.

  PPAR research 20080101

• Should We Use PPAR Agonists to Reduce Cardiovascular Risk?

  PPAR research 20080101

• Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.

  BMC health services research 20080101

• ONTARGET programme of cardio- and vascular protection - first results are imminent.

  Cardiovascular journal of Africa 20080101

• [Beneficial effects of Hartil on cardiovascular remodeling process in elderly and old patients with isolated systolic arterial hypertension].

  Georgian medical news 20080101

• Bayesian meta-analysis of tissue angiotensin-converting enzyme inhibitors for reduction of adverse cardiovascular events in patients with diabetes mellitus and preserved left ventricular function.

  Journal of the cardiometabolic syndrome 20080101

• Aliskiren: renin inhibitor for hypertension management.

  Clinical therapeutics 20080101

• The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.

  BMC nephrology 20080101

• Flow-volume loops derived from three-dimensional echocardiography: a novel approach to the assessment of left ventricular hemodynamics.

  Cardiovascular ultrasound 20080101

• Prevalence of chronic kidney disease in population-based studies: systematic review.

  BMC public health 20080101

• Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus.

  Cardiovascular diabetology 20080101

• Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

  Cardiovascular diabetology 20080101

• Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis--a CMR study.

  Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20080101

• No HOPE without proof: do ARBs meet the standard for cardiovascular protection?

  Medscape journal of medicine 20080101

• Cardiac and vascular protection: the potential of ONTARGET.

  Medscape journal of medicine 20080101

• Targeting cardiovascular protection: the concept of dual renin-angiotensin system control.

  Medscape journal of medicine 20080101

• Infective endocarditis caused by Staphylococcus aureus in a patient with atopic dermatitis: a case report.

  Journal of medical case reports 20080101

• [spACE, the last frontier? Renin inhibition in hypertension].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20080101

• ONTARGET proves telmisartan efficacy compared to ramipril in cardiovascular protection of patients at high risk and without heart failure.

  Cardiovascular journal of Africa 20080101

• NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.

  PloS one 20080101

• [Telmisartan, ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial].

  Kardiologiia 20080101

• A genome-wide search replicates evidence of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE) unlinked to the ACE gene.

  BMC medical genomics 20080101

• Henoch-Schönlein purpura with intracerebral haemorrhage in an adult patient: a case report.

  Journal of medical case reports 20080101

• Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure.

  Cardiovascular ultrasound 20080101

• A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.

  Blood pressure 20080101

• Clinical pharmacokinetics and pharmacodynamics of aliskiren.

  Clinical pharmacokinetics 20080101

• First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.

  Cardiovascular diabetology 20080101

• Late-life somnambulism after therapy with metoprolol.

  Clinical neuropharmacology 20080101

• Vesicoureteral reflux, reflux nephropathy, and end-stage renal disease.

  Advances in urology 20080101

• Lessons from ONTARGET.

  Acta clinica Belgica 20080101

• [Clinico-economical efficacy of angiotensin converting enzyme inhibitors in patients with arterial hypertension and ischemic heart disease].

  Kardiologiia 20080101

• Antihypertensive drug class and impaired fasting glucose: a risk association study among Chinese patients with uncomplicated hypertension.

  BMC clinical pharmacology 20080101

• [Investigation of converting enzyme inhibitors in patients, survivors of myocardial infarction].

  Kardiologiia 20080101

• Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation.

  Cases journal 20080101

• Abdominal pain in an adult with Type 2 diabetes: A case report.

  Cases journal 20080101

• Modulation of pain perception by ramipril and losartan in human volunteers.

  Indian journal of physiology and pharmacology 20080101

• [Advances in diabetes mellitus, diabetic nephropathy, metabolic syndrome and cardio-vascular-renal risk].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101

• Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.

  Lipids in health and disease 20080101

• Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?

  Cerebrovascular diseases (Basel, Switzerland) 20080101

• Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.

  Journal of gastroenterology 20080101

• Hypoalbuminaemia--a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV.

  International journal of medical sciences 20080101

• Anomalous origin of the left circumflex artery from the right coronary artery: a case report.

  Cases journal 20080101

• Cardiovascular risk and cardiometabolic protection: role of glitazones.

  Journal of nephrology 20080101

• [Double blockade of the renin-angiotensin system (RAS): what has the ONTARGET study taught us?].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20080101

• Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report.

  Cases journal 20080101

• Association of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont diabetes information system.

  BMC endocrine disorders 20080101

• [Parameters of vasomotor function of endothelium and elasticity of arterial wall during therapy with angiotensin converting enzyme inhibitor ramiprilin patients with type 2 diabetes mellitus].

  Kardiologiia 20080101

• [The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].

  Kardiologiia 20080101

• Septic rupture of the ascending aorta after aortocoronary bypass surgery.

  Journal of cardiothoracic surgery 20080101

• Circulating tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) in systemic sclerosis patients with elevated pulmonary arterial pressure.

  Mediators of inflammation 20080101

• Ramipril: the better angiotensin-converting enzyme inhibitor?

  Indian heart journal 20080101

• Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.

  Indian heart journal 20080101

• Renin-angiotensin-aldosterone system (RAAS) block revisited.

  The National medical journal of India 20080101

• Peroxisome proliferator-activated receptors in diabetic nephropathy.

  PPAR research 20080101

• [Hartil effects on structural-functional condition of the heart in patients with chronic cor pulmonale].

  Terapevticheskii arkhiv 20080101

• Optimized and validated spectrophotometric methods for the determination of enalapril maleate in commercial dosage forms.

  Analytical chemistry insights 20080101

• Impact of preoperative mild renal dysfunction on short term outcome in isolated Coronary Artery Bypass (CABG) patients.

  Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 20080101

• Validated HPTLC Method for Simultaneous Determination of Quinapril Hydrochloride and Hydrochlorothiazide in a Tablet Dosage Form.

  Indian journal of pharmaceutical sciences 20080101

• Ramipril enhances the endogenous hydrogen sulfide tissue concentration in mouse heart and brain.

  Folia medica Cracoviensia 20080101

• 24-hour powerful blood pressure-lowering: is there a clinical need?

  Journal of the American Society of Hypertension : JASH 20080101

• Is the combination of enalapril and losartan irrational?

  Indian journal of pharmacology 20080101

• [Therapy of hypertension with expanded outlook. Constant pressure decline and organ protection].

  MMW Fortschritte der Medizin 20071206

• Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: a comparative study.

  European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20071201

• Chronic kidney disease in children: the global perspective.

  Pediatric nephrology (Berlin, Germany) 20071201

• Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination.

  Arteriosclerosis, thrombosis, and vascular biology 20071201

• Direct effects of the angiotensin-converting enzyme inhibitor ramiprilat on adult rat ventricular cardiomyocytes.

  Acta physiologica (Oxford, England) 20071201

• Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies.

  Cardiovascular drugs and therapy 20071201

• Prevention of Type 2 diabetes: fact or fiction?

  Expert opinion on pharmacotherapy 20071201

• Diabetes prevention: still no effective drugs.

  Prescrire international 20071201

• Beneficial effects of ramipril on myocardial diastolic function in patients with type 2 diabetes mellitus, normal LV systolic function and without coronary artery disease: a prospective study using tissue Doppler.

  Diabetes & vascular disease research 20071201

• Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension.

  Vascular health and risk management 20071201

• Clinical trial update: focus on the ONTARGET study.

  Vascular health and risk management 20071201

• Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature.

  Vascular health and risk management 20071201

• Reduction of C-reactive protein and the use of anti-hypertensives.

  Vascular health and risk management 20071201

• Rationale for multiple risk intervention: the need to move from theory to practice.

  Vascular health and risk management 20071201

• Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease.

  Vascular health and risk management 20071201

• Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy.

  Vascular health and risk management 20071201

• Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20071201

• Peripheral arterial disease in the elderly.

  Clinical interventions in aging 20071201

• Induced hypertensive therapy in an acute ischemic stroke patient with early neurological deterioration.

  Journal of clinical neurology (Seoul, Korea) 20071201

• The CETP TaqIB polymorphism is associated with the risk of sudden death in type 2 diabetic patients.

  Diabetes care 20071101

• Effects of ACE inhibition and beta-blockade on female genital structures in spontaneously hypertensive rats.

  The journal of sexual medicine 20071101

• Complement in glomerular injury.

  Seminars in immunopathology 20071101

• Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.

  European journal of heart failure 20071101

• Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients.

  Journal of clinical hypertension (Greenwich, Conn.) 20071101

• Liquid chromatography tandem mass spectrometry method for simultaneous determination of metoprolol tartrate and ramipril in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015

• Connexin40 regulates renin production and blood pressure.

  Kidney international 20071001

• Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.

  Kidney international 20071001

• [Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)].

  Der Internist 20071001

• Albuminuria reduction: the holy grail for kidney protection.

  Kidney international 20071001

• Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.

  Journal of hypertension 20071001

• Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients.

  Journal of hypertension 20071001

• Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor.

  Radiation research 20071001

• Nebivolol in the treatment of chronic heart failure.

  Vascular health and risk management 20071001

• Effect of ramipril on the incidence of diabetes.

  Current atherosclerosis reports 20071001

• Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes.

  Atherosclerosis 20070901

• Target-controlled infusion of propofol combined with variable rate infusion of remifentanil for anaesthesia of a dog with patent ductus arteriosus.

  Veterinary anaesthesia and analgesia 20070901

• Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.

  American heart journal 20070901

• Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.

  American journal of hypertension 20070901

• Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.

  PLoS medicine 20070901

• Rationale for double renin-angiotensin-aldosterone system blockade.

  The American journal of cardiology 20070806

• Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?

  The American journal of cardiology 20070806

• New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

  The American journal of cardiology 20070806

• Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study.

  European journal of clinical pharmacology 20070801

• Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.

  British journal of pharmacology 20070801

• The new clinical trials with thiazolidinediones--DREAM, ADOPT, and CHICAGO: promises fulfilled?

  Current opinion in lipidology 20070801

• ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trial.

  Cardiovascular drugs and therapy 20070801

• Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians.

  American journal of hypertension 20070801

• Noninvasive pulse waveform analysis in clinical trials: similarity of two methods for calculating aortic systolic pressure.

  American journal of hypertension 20070801

• Haemodynamic effects in healthy horses treated with an ACE-inhibitor (Ramipril).

  Veterinary research communications 20070801

• Pharmaceutical brand substitution in Australia--are there multiple switches per prescription?

  Australian and New Zealand journal of public health 20070801

• Effect of ramipril on the incidence of diabetes (DREAM Study).

  Current atherosclerosis reports 20070801

• PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.

  Vascular health and risk management 20070801

• Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study).

  Vascular health and risk management 20070801

• Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.

  Vascular health and risk management 20070801

• The burden of type 2 diabetes: strategies to prevent or delay onset.

  Vascular health and risk management 20070801

• Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors.

  Vascular health and risk management 20070801

• Assessment of single versus twice daily dosing of ramipril by ambulatory blood pressure monitoring in patients similar to those included in the HOPE study.

  Journal of human hypertension 20070701

• Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent.

  Pharmacological research 20070701

• Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND).

  American heart journal 20070701

• Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.

  Diabetes care 20070601

• Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.

  European heart journal 20070601

• [ACE inhibitors after myocardial infarction: close-up on zofenopril].

  Annales de cardiologie et d'angeiologie 20070601

• Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients.

  European heart journal 20070601

• The effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials.

  Blood pressure monitoring 20070601

• Delayed recovery of left ventricular systolic dysfunction: ''give time to medical therapy''.

  Minerva cardioangiologica 20070601

• Formulation development and optimization using nanoemulsion technique: a technical note.

  AAPS PharmSciTech 20070601

• The blockade of the renin-angiotensin system reverses tacrolimus related cardiovascular toxicity at the histopathological level.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20070601

• Manidipine-delapril combination in the management of hypertension.

  Vascular health and risk management 20070601

• Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.

  Vascular health and risk management 20070601

• Multivariate risk assessment and risk score cards in hypertension.

  Vascular health and risk management 20070601

• [Three studies in type 2 diabetes: DREAM the wash-out results].

  Annales d'endocrinologie 20070601

• Development and bioavailability assessment of ramipril nanoemulsion formulation.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070501

• Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor.

  Pharmacogenetics and genomics 20070501

• Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.

  Circulation 20070417

• Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: importance of ramipril dose and treatment time.

  Journal of neuro-oncology 20070401

• Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients.

  Journal of human hypertension 20070401

• Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats.

  Naunyn-Schmiedeberg's archives of pharmacology 20070401

• Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.

  Journal of the American Society of Nephrology : JASN 20070401

• Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.

  Nephrology (Carlton, Vic.) 20070401

• Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.

  American journal of hypertension 20070401

• [New therapeutic targets for ACE inhibitors and angiotensin receptor blockers].

  Polskie Archiwum Medycyny Wewnetrznej 20070401

• Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk.

  Circulation 20070320

• Trials that matter: rosiglitazone, ramipril, and the prevention of type 2 diabetes.

  Annals of internal medicine 20070320

• Spectrophotometric and spectrofluorimetric methods for the determination of ramipril in its pure and dosage form.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070301

• Interstitial remodeling in beta1-adrenergic receptor transgenic mice.

  Basic research in cardiology 20070301

• Effects of ACE inhibition and beta-blockade on plasminogen activator inhibitor-1 and transforming growth factor-beta1 in carotid glomus and autonomic ganglia in hypertensive rats.

  American journal of hypertension 20070301

• Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.

  Expert review of cardiovascular therapy 20070301

• Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.

  The Annals of pharmacotherapy 20070301

• Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.

  European journal of clinical investigation 20070301

• The therapeutic effects of angiotensin-converting enzyme inhibitors in severe non-proliferative diabetic retinopathy.

  Korean journal of ophthalmology : KJO 20070301

• Commentary. Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial.

  Perspectives in vascular surgery and endovascular therapy 20070301

• Angiotensin-converting enzyme inhibitors and coronary heart disease prevention.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20070301

• Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension.

  Journal of clinical biochemistry and nutrition 20070301

• Optimal timing for antihypertensive dosing: focus on valsartan.

  Therapeutics and clinical risk management 20070301

• Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.

  Journal of the American College of Cardiology 20070220

• Investigation of the effect of a countywide protected learning time scheme on prescribing rates of ramipril: interrupted time series study.

  Family practice 20070201

• Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?

  Endocrinology 20070201

• Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.

  Hypertension (Dallas, Tex. : 1979) 20070201

• Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients.

  Journal of hypertension 20070201

• Severe lactic acidosis and rhabdomyolysis following metformin and ramipril overdose.

  British journal of anaesthesia 20070201

• The DREAM Trial: using ramipril and rosiglitazone to prevent diabetes.

  Current diabetes reports 20070201

• DREAM and ADOPT: rosiglitazone does what it says on the packet.

  Diabetic medicine : a journal of the British Diabetic Association 20070201

• Effect of ramipril on the incidence of diabetes.

  The New England journal of medicine 20070201

• Effect of ramipril on the incidence of diabetes.

  The New England journal of medicine 20070201

• Effect of ramipril on the incidence of diabetes.

  The New England journal of medicine 20070201

• Acute upper airway obstruction from acquired angioedema.

  Emergency medicine Australasia : EMA 20070201

• [Fasciitis with eosinophilia: a possible causal role of angiotensin converting enzyme inhibitor].

  Revue neurologique 20070201

• Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.

  Vascular health and risk management 20070201

• Moexipril and left ventricular hypertrophy.

  Vascular health and risk management 20070201

• Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.

  Vascular health and risk management 20070201

• Trandolapril/verapamil combination in hypertensive diabetic patients.

  Vascular health and risk management 20070201

• Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.

  Vascular health and risk management 20070201

• Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial.

  Vascular health and risk management 20070201

• [The DREAM of diabetes prevention].

  Revue medicale suisse 20070117

• Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase.

  American journal of physiology. Renal physiology 20070101

• Therapeutic approach to FSGS in children.

  Pediatric nephrology (Berlin, Germany) 20070101

• A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.

  Journal of hypertension 20070101

• Ramipril did not reduce incident diabetes in patients with impaired glycemic control.

  ACP journal club 20070101

• A long-term 'memory' of HIF induction in response to chronic mild decreased oxygen after oxygen normalization.

  BMC cardiovascular disorders 20070101

• Heterogeneity of human adipose blood flow.

  BMC clinical pharmacology 20070101

• Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.

  Journal of cardiovascular pharmacology 20070101

• Ramipril in post-renal transplant erythrocytosis.

  Journal of nephrology 20070101

• Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria.

  Renal failure 20070101

• Propylthiouracil-induced vasculitis associated with ANCA: a case report.

  Renal failure 20070101

• The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.

  Reviews in cardiovascular medicine 20070101

• [The best of epidemiology and cardiovascular prevention in 2006].

  Archives des maladies du coeur et des vaisseaux 20070101

• Takotsubo cardiomyopathy in a Caucasian Italian woman: case report.

  Cardiovascular ultrasound 20070101

• Angiotensin-converting enzyme inhibitors in veterinary medicine.

  Current pharmaceutical design 20070101

• The effect of ramipril therapy on cytokines and parameters of incipient diabetic nephropathy in patients with type 1 diabetes mellitus.

  The Journal of international medical research 20070101

• Experimental concepts for toxicity prevention and tissue restoration after central nervous system irradiation.

  Radiation oncology (London, England) 20070101

• Ileostomy and ramipril-induced acute renal failure and shock.

  Heart & lung : the journal of critical care 20070101

• Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis.

  BMC nephrology 20070101

• Aliskiren: a review of its use in the management of hypertension.

  Drugs 20070101

• Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial.

  Journal of the cardiometabolic syndrome 20070101

• Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes.

  Cardiovascular diabetology 20070101

• Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.

  Blood purification 20070101

• Clinical decision making and the expected value of information.

  Clinical trials (London, England) 20070101

• [Anaphylactoid reaction in hemodyalisis: converting enzyme inhibitors interaction with no PAN 69 membrane].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20070101

• Effect of ramipril therapy on cognitive functions in cases of mild to moderate essential hypertension.

  Indian journal of physiology and pharmacology 20070101

• Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project.

  BMC public health 20070101

• Comparison of persistence rates with angiotensin-converting enzyme inhibitors used in secondary and primary prevention of cardiovascular disease.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20070101

• A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study.

  BMC medical genetics 20070101

• Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study.

  Cardiovascular diabetology 20070101

• Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.

  Clinical drug investigation 20070101

• A perspective on telmisartan and cardiovascular risk.

  Reviews in cardiovascular medicine 20070101

• Atrial fibrillation-related cardiomyopathy: a case report.

  Journal of medical case reports 20070101

• Medicinal importance of grapefruit juice and its interaction with various drugs.

  Nutrition journal 20070101

• Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting.

  Thrombosis journal 20070101

• The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes and hypertension in Ontario, Canada.

  Implementation science : IS 20070101

• Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study.

  Cardiovascular diabetology 20070101

• Estimating the cost effectiveness of ramipril used for specific clinical indications: comparing the outcomes in four clinical trials with a common economic model.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20070101

• Aliskiren: an oral renin inhibitor for the treatment of hypertension.

  Cardiology in review 20070101

• The Functions of PPARs in Aging and Longevity.

  PPAR research 20070101

• Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis.

  Journal of the American Society of Hypertension : JASH 20070101

• Telmisartan ramipril combination therapy reduces strokes and improves cardiac and renal protection in stroke prone spontaneously hypertensive rats.

  Journal of the American Society of Hypertension : JASH 20070101

• Perindopril: the evidence of its therapeutic impact in hypertension.

  Core evidence 20070101

• Tako-tsubo cardiomyopathy.

  The Libyan journal of medicine 20070101

• Endothelial dysfunction, erectile dysfunction and phosphodiesterase 5 inhibitors. An update of the current data and future perspectives.

  Drug target insights 20070101

• Nitric oxide and cardiovascular risk factors.

  Heart international 20070101

• [Experiences of the DREAM trial].

  Orvosi hetilap 20061231

• Effect of short-term ACE inhibitor treatment on peripheral insulin sensitivity in obese insulin-resistant subjects.

  Diabetologia 20061201

• Why are mineralocorticoid receptor antagonists cardioprotective?

  Naunyn-Schmiedeberg's archives of pharmacology 20061201

• Redefining the ACE-inhibitor dose-response relationship: substantial blood pressure lowering after massive doses.

  European journal of clinical pharmacology 20061201

• Lichen planus pemphigoides associated with ramipril.

  International journal of dermatology 20061201

• Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis.

  Nephrology (Carlton, Vic.) 20061201

• Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.

  Vascular health and risk management 20061201

• Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects.

  Vascular health and risk management 20061201

• Role of angiotensin II in retinal leukostasis in the diabetic rat.

  Experimental eye research 20061101

• Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil.

  Journal of hypertension 20061101

• Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20061101

• Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.

  International journal of clinical practice 20061101

• Effects of blockade of the renin-angiotensin and endothelin systems on experimental bronchiolitis obliterans.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20061101

• Effect of ramipril on the incidence of diabetes.

  The New England journal of medicine 20061012

• Angiotensin-converting-enzyme inhibitors for impaired glucose tolerance--is there still hope?

  The New England journal of medicine 20061012

• Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.

  International journal of cardiology 20061010

• Different pathomechanisms of essential and obesity-associated hypertension in adolescents.

  Pediatric nephrology (Berlin, Germany) 20061001

• Lessons from the African-American Study of Kidney Disease and Hypertension: an update.

  Current hypertension reports 20061001

• Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.

  American journal of hypertension 20061001

• [DREAM study: prevention of type 2 diabetes with ramipril and/or rosiglitazone in persons with dysglycaemia but no cardiovascular desease].

  Revue medicale de Liege 20061001

• DREAM study and its impact on India.

  The Journal of the Association of Physicians of India 20061001

• Impact of ramipril on the circadian periodicity of acute myocardial infarction.

  The American journal of cardiology 20060915

• Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial.

  Journal of human hypertension 20060901

• Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?

  European heart journal 20060901

• Angiotensin-converting enzyme inhibition reduces lipid deposits in myocardium and improves left ventricular function of obese zucker rats.

  Obesity (Silver Spring, Md.) 20060901

• Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20060901

• A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours.

  Vascular health and risk management 20060901

• Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease.

  Vascular health and risk management 20060901

• Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.

  The Journal of surgical research 20060801

• Lack of effect on coronary atherosclerotic disease biomarkers with modest dosing of an angiotensin-converting enzyme inhibitor, angiotensin II type-1 receptor blocker, and the combination.

  Coronary artery disease 20060801

• Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis.

  Journal of Zhejiang University. Science. B 20060801

• [HOPE study].

  Nihon rinsho. Japanese journal of clinical medicine 20060801

• [Mechanism of Shenqi compound recipe anti-earlier diabetic artherosclerosis in GK rats].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20060801

• Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.

  Circulation 20060718

• Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin.

  Blood 20060701

• Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats.

  Endocrinology 20060701

• Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction?

  The American journal of cardiology 20060701

• The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.

  Journal of hypertension 20060701

• Effects of ramipril on renal function during progressive overpacing-induced heart failure in dogs.

  American journal of veterinary research 20060701

• Oxidative stress: a potentially important new marker in renal transplantation.

  The Journal of pediatrics 20060701

• Ramipril treatment protects against nitrate-induced oxidative stress in eNOS-/- mice: An implication of the NADPH oxidase pathway.

  Journal of cardiovascular pharmacology 20060701

• [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].

  MMW Fortschritte der Medizin 20060629

• First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060606

• Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.

  Diabetes research and clinical practice 20060601

• Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20060601

• Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.

  Diabetes care 20060601

• Can thiazolidinediones delay disease progression in type 2 diabetes?

  Current medical research and opinion 20060601

• A review of Perindopril in the reduction of cardiovascular events.

  Vascular health and risk management 20060601

• Valsartan in the treatment of heart attack survivors.

  Vascular health and risk management 20060601

• High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system.

  Journal of cellular biochemistry 20060515

• Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.

  European journal of pharmacology 20060510

• Summaries for patients. Ramipril improves walking ability in patients with peripheral arterial disease.

  Annals of internal medicine 20060502

• Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial.

  Annals of internal medicine 20060502

• Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns.

  The American journal of medicine 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Lichenoid and granulomatous stomatitis: an entity or a non-specific inflammatory process?

  Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20060501

• [Did a reform strategy in drug management improve doctors' prescribing habits in Montenegro: the example for the cardiovascular drugs].

  Vojnosanitetski pregled 20060501

• Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.

  Archives of internal medicine 20060410

• Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.

  Clinical research in cardiology : official journal of the German Cardiac Society 20060401

• Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20060401

• Hypertension treatment and implications of recent cardiovascular outcome trials.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20060401

• Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060301

• Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.

  Hypertension (Dallas, Tex. : 1979) 20060301

• Smart damping modulation of carotid wall energetics in human hypertension: effects of angiotensin-converting enzyme inhibition.

  Hypertension (Dallas, Tex. : 1979) 20060301

• Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.

  Journal of hypertension 20060301

• Effect of ramipril on left ventricular mass in normotensive hemodialysis patients.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20060301

• Initiation of hypertension treatment with a fixed-dose combination or its monocomponents -- does it really matter?

  International journal of clinical practice 20060301

• [Effects and mechanism of ShenQi compound recipe on inflammation maker in GK rats].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20060301

• Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.

  Clinical journal of the American Society of Nephrology : CJASN 20060301

• Interference from a glucuronide metabolite in the determination of ramipril and ramiprilat in human plasma and urine by gas chromatography-mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20060224

• High-performance liquid chromatography-mass spectrometric analysis of ramipril and its active metabolite ramiprilat in human serum: application to a pharmacokinetic study in the Chinese volunteers.

  Journal of pharmaceutical and biomedical analysis 20060213

• Liquid chromatographic separation and UV determination of certain antihypertensive agents.

  Biomedical chromatography : BMC 20060201

• Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate.

  Pediatric nephrology (Berlin, Germany) 20060201

• Comparative bioavailability of two ramipril formulations after single-dose administration in healthy volunteers.

  International journal of clinical pharmacology and therapeutics 20060201

• ACE inhibition in secondary prevention: are the results controversial?

  Clinical research in cardiology : official journal of the German Cardiac Society 20060201

• Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation.

  Medical hypotheses 20060101

• Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.

  The Journal of pharmacology and experimental therapeutics 20060101

• The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I).

  Journal of hypertension 20060101

• Minimal change disease in association with fire coral (Millepora species) exposure.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20060101

• Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.

  BMC clinical pharmacology 20060101

• Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.

  Clinical pharmacology and therapeutics 20060101

• Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.

  Acta anaesthesiologica Scandinavica 20060101

• A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.

  American journal of hypertension 20060101

• Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy.

  The international journal of cardiovascular imaging 20060101

• Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients.

  BMC nephrology 20060101

• Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.

  BMC health services research 20060101

• Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care.

  BMC cardiovascular disorders 20060101

• Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?

  BMC family practice 20060101

• A randomized trial to assess the impact of opinion leader endorsed evidence summaries on the use of secondary prevention strategies in patients with coronary artery disease: the ESP-CAD trial protocol [NCT00175240].

  Implementation science : IS 20060101

• Pharmacokinetic and pharmacodynamic parameters of ramipril and ramiprilat in healthy dogs and dogs with reduced glomerular filtration rate.

  Journal of veterinary internal medicine 20060101

• Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.

  Blood pressure 20060101

• Effects of an interactive CD-program on 6 months readmission rate in patients with heart failure - a randomised, controlled trial [NCT00311194].

  BMC cardiovascular disorders 20060101

• A critical review of mathematical models and data used in diabetology.

  Biomedical engineering online 20060101

• Arterial hypertension and stroke prevention: an update.

  Clinical and experimental hypertension (New York, N.Y. : 1993) 20060101

• Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report.

  BMC cancer 20060101

• Essential mixed cryoglobulinemia type II.

  Clinical and experimental rheumatology 20060101

• C-reactive protein (CRP)-lowering agents.

  Cardiovascular drug reviews 20060101

• A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. 'ARAMIA'.

  Trials 20060101

• ACE inhibitors and angiotensin II receptor blockers in IgA nephropathy with mild proteinuria: the ACEARB study.

  Journal of nephrology 20060101

• The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure.

  Journal of veterinary internal medicine 20060101

• Quantification of trandolapril and its metabolite trandolaprilat in human plasma by liquid chromatography/tandem mass spectrometry using solid-phase extraction.

  Rapid communications in mass spectrometry : RCM 20060101

• Changes in heart failure medications in patients hospitalised and discharged.

  BMC family practice 20060101

• Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.

  Kidney & blood pressure research 20060101

• Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey.

  BMC medicine 20060101

• Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease.

  BMC cardiovascular disorders 20060101

• Ramipril: a review of its use in preventing cardiovascular outcomes in high-risk patients.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20060101

• Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions.

  Chinese medicine 20060101

• The question of whether diabetes and its cardiovascular risks can be prevented: a realistic DREAM?

  Blood pressure 20060101

• Percutaneous resection of renal urothelial carcinoma using bipolar electrocautery.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20060101

• Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trial.

  Heart international 20060101

• Insulin-sensitizing and cardiovascular effects of the sodium-hydrogen exchange inhibitor, cariporide, in the JCR: LA-cp rat and db/db mouse.

  Journal of cardiovascular pharmacology 20051201

• Cardioprotective activity of alcoholic extract of Tinospora cordifolia in ischemia-reperfusion induced myocardial infarction in rats.

  Biological & pharmaceutical bulletin 20051201

• Do all patients with coronary artery disease benefit from angiotensin converting enzyme inhibitors?

  Journal of cardiovascular pharmacology and therapeutics 20051201

• Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors?

  Clinical cardiology 20051201

• [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].

  Zhonghua yi xue za zhi 20051130

• Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats.

  Neuroreport 20051128

• [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005].

  Deutsche medizinische Wochenschrift (1946) 20051125

• [Hypertension and diabetic nephropathy, a dangerous duo].

  Medizinische Klinik (Munich, Germany : 1983) 20051115

• Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction.

  British journal of pharmacology 20051101

• Effects of an angiotensin-converting enzyme inhibitor (ramipril) on inflammatory markers in secondary prevention patients: RAICES Study.

  Coronary artery disease 20051101

• Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity.

  American heart journal 20051101

• Tolerability of ramipril 10 mg daily in high-risk cardiovascular patients in Taiwan: experience from Kaohsiung Medical University Chung-Ho Memorial Hospital.

  The Kaohsiung journal of medical sciences 20051101

• [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].

  Italian heart journal : official journal of the Italian Federation of Cardiology 20051101

• Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors.

  Presse medicale (Paris, France : 1983) 20051022

• Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.

  Arthritis and rheumatism 20051015

• Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible.

  Canadian family physician Medecin de famille canadien 20051010

• The African American Study of Kidney Disease: do these results indicate that 140/90 mm hg is good enough?

  Current hypertension reports 20051001

• Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.

  Diabetes 20051001

• Effects of ramipril on arterial stiffness.

  Hypertension (Dallas, Tex. : 1979) 20051001

• Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

  Prescrire international 20051001

• [A patient with severe hyperkalaemia -- an emergency after RALES].

  Deutsche medizinische Wochenschrift (1946) 20050909

• The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

  Diabetologia 20050901

• Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis.

  Atherosclerosis 20050901

• Ramipril in the treatment of vascular diseases.

  Expert opinion on pharmacotherapy 20050901

• The prevention of type 2 diabetes: what is the evidence?

  Minerva endocrinologica 20050901

• Kinetic spectrophotometric method for the determination of ramipril in pharmaceutical formulations.

  AAPS PharmSciTech 20050901

• Lercanidipine in hypertension.

  Vascular health and risk management 20050901

• Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.

  Vascular health and risk management 20050901

• Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.

  Circulation 20050830

• Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

  Journal of the American Society of Nephrology : JASN 20050801

• Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?

  Journal of hypertension 20050801

• Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.

  Diabetologia 20050801

• An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy.

  Expert opinion on pharmacotherapy 20050801

• Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.

  European journal of heart failure 20050801

• Cardiovascular events in hypertension trials of Angiotensin-converting enzyme inhibitors.

  Journal of clinical hypertension (Greenwich, Conn.) 20050801

• [Effects of angiotensin receptor blocker and angiotensin-coverting enzyme inhibitor on vascular endothelial function in type 2 diabetic patients with atherosclerosis: a comparative study].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050801

• Validated ligand mapping of ACE active site.

  Journal of computer-aided molecular design 20050801

• Ramipril induced polyserositis with pericardial tamponade and pleural effusion.

  International journal of cardiology 20050710

• [Experiences with the realisation of innovative study designs using the example of the HOPE-study].

  Deutsche medizinische Wochenschrift (1946) 20050708

• Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050701

• Blood pressure control, drug therapy, and kidney disease.

  Hypertension (Dallas, Tex. : 1979) 20050701

• Renal failure following bowel cleansing with a sodium phosphate purgative.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050701

• Ramipril prevents extracellular matrix accumulation in cerebral microvessels.

  Neurological research 20050701

• Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes.

  Hypertension (Dallas, Tex. : 1979) 20050601

• Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.

  Journal of hypertension 20050601

• Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture.

  Hypertension (Dallas, Tex. : 1979) 20050601

• Comparison of the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus.

  The American journal of cardiology 20050601

• [Association between angiotensin converting enzyme I/D polymorphism and high-sensitivity C-reactive protein in type 2 diabetic patients with atherosclerosis treated with ramipril].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular events.

  Current medical research and opinion 20050601

• The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: a randomized clinical study.

  Clinical cardiology 20050601

• Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?

  Vascular health and risk management 20050601

• Have angiotensin receptor blockers lived up to expectations?

  The Canadian journal of cardiology 20050515

• The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.

  Cardiology clinics 20050501

• Comparative effects of the angiotensin II receptor blocker, telmisartan, and the angiotensin-converting enzyme inhibitor, ramipril, on cerebrovascular structure in spontaneously hypertensive rats.

  Journal of hypertension 20050501

• Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20050501

• Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis.

  Zeitschrift fur Kardiologie 20050501

• The HOPE TIPS: the HOPE study translated into practices.

  Cardiovascular drugs and therapy 20050501

• Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction.

  Life sciences 20050429

• Stability of ramipril in the solvents of different pH.

  Journal of pharmaceutical and biomedical analysis 20050429

• The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.

  Archives of internal medicine 20050425

• Inhibition of angiotensin-converting enzyme and phosphodiesterase type 5 improves endothelial function in heart failure.

  Clinical science (London, England : 1979) 20050401

• Managing the patient at risk for a second stroke.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20050401

• The cardiovascular continuum and renin-angiotensin-aldosterone system blockade.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20050401

• Role of echocardiography in assessing the mechanism and effect of ramipril on functional mitral regurgitation in dilated cardiomyopathy.

  Echocardiography (Mount Kisco, N.Y.) 20050401

• The ONTARGET/TRANSCEND Trial Programme: baseline data.

  Acta diabetologica 20050401

• LC-MS determination and bioavailability study of imidapril hydrochloride after the oral administration of imidapril tablets in human volunteers.

  Archives of pharmacal research 20050401

• ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.

  Neuroscience letters 20050316

• Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition.

  Journal of internal medicine 20050301

• Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery?

  Journal of hypertension 20050301

• Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.

  Journal of hypertension 20050301

• Renoprotective therapy: is it blood pressure or albuminuria that matters?

  Lancet (London, England) 20050301

• Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

  Lancet (London, England) 20050301

• Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.

  Clinical nephrology 20050301

• Efficacy and safet of pimobendan in canine heart failure caused by myxomatous mitral valve disease.

  The Journal of small animal practice 20050301

• Pregnancy outcome following exposure to orlistat, ramipril, glimepiride in a woman with metabolic syndrome.

  Saudi medical journal 20050301

• Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.

  Transplantation proceedings 20050301

• Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses.

  Journal of the American Society of Nephrology : JASN 20050301

• Taking diltiazem ER in the evening reduces morning blood pressure and heart rate more than ramipril. Commentary.

  Evidence-based cardiovascular medicine 20050301

• In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.

  Vascular health and risk management 20050301

• Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium.

  Vascular health and risk management 20050301

• Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.

  Therapeutics and clinical risk management 20050301

• Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents.

  Journal of the American Society of Nephrology : JASN 20050201

• Myocardial infarction increases ACE2 expression in rat and humans.

  European heart journal 20050201

• Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20050201

• Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.

  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20050201

• Case-based study: from prediabetes to complications--opportunities for prevention.

  PLoS medicine 20050201

• The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.

  Canadian journal of physiology and pharmacology 20050201

• Sirolimus and ACE-inhibitors: a note of caution.

  Transplantation 20050127

• Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.

  Chinese medical journal 20050120

• Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure.

  The American journal of cardiology 20050115

• Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation.

  American journal of physiology. Renal physiology 20050101

• Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells.

  Hypertension (Dallas, Tex. : 1979) 20050101

• Ramipril-induced agranulocytosis confirmed by a lymphocyte cytotoxicity test.

  The American journal of the medical sciences 20050101

• Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.

  American journal of hypertension 20050101

• Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.

  American journal of hypertension 20050101

• Preventing type 2 diabetes mellitus.

  The Journal of the American Board of Family Practice 20050101

• Blockade of the renin-angiotensin system increases plasma adiponectin levels in type-2 diabetic patients with proteinuria.

  Nephron. Clinical practice 20050101

• A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101

• The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].

  BMC medicine 20050101

• Pharmacologic treatment of chronic pediatric hypertension.

  Paediatric drugs 20050101

• Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.

  Cardiovascular diabetology 20050101

• Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?

  BMC family practice 20050101

• Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome.

  Cardiovascular diabetology 20050101

• Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey.

  BMC cardiovascular disorders 20050101

• Some fundamental and technical aspects of the quantitative analysis of pharmaceutical drugs by matrix-assisted laser desorption/ionization mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20050101

• Peripheral arterial disease: a high risk - but neglected - disease population.

  BMC cardiovascular disorders 20050101

• Progression of kidney disease in type 2 diabetes - beyond blood pressure control: an observational study.

  BMC nephrology 20050101

• [Similar reduction in new cases of type 2 diabetes with angiotensin receptor blocker and ACE inhibitor: comparison of meta-analyses of prospective randomised trials].

  Revue medicale de Liege 20050101

• ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression.

  Journal of vascular research 20050101

• The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.

  Scandinavian journal of clinical and laboratory investigation. Supplementum 20050101

• Ramipril/felodipine extended-release fixed-dose combination: a review of its use in the management of essential hypertension.

  Drugs 20050101

• [Olmesartan after experimental myocardial infarct compared with ramipril: organ protective effect].

  Krankenpflege Journal 20050101

• Pre-clinical and clinical experience of telmisartan in cardiac remodelling.

  The Journal of international medical research 20050101

• Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients.

  The Journal of international medical research 20050101

• Rationale and design of the cardiac magnetic resonance imaging substudy of The ONTARGET Trial Programme.

  The Journal of international medical research 20050101

• [Angiotensin converting enzyme inhibitors in patients with ischemic heart disease: in all cases or in high risk of complications].

  Kardiologiia 20050101

• Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.

  Current controlled trials in cardiovascular medicine 20050101

• Effect of pre-operative angiotensin-converting enzyme inhibitors on haemodynamic parameters and vasoconstrictor requirements in patients undergoing off-pump coronary artery bypass surgery.

  The Journal of international medical research 20050101

• Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria.

  Lupus 20050101

• Picture Quiz: An unusual cause of headache.

  Acute medicine 20050101

• Aliskiren in hypertension: evidence for its potential therapeutic value.

  Core evidence 20050101

• Role of the sympathetic and renin angiotensin systems in the glucose-induced increase of blood pressure in rats.

  European journal of pharmacology 20041215

• The PROGRESS trial three years later: HOPE trial may shed some light.

  BMJ (Clinical research ed.) 20041211

• ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.

  Biochemical and biophysical research communications 20041210

• Manipulation of the renin angiotensin system in peripheral arterial disease.

  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20041201

• Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?

  Medical science monitor : international medical journal of experimental and clinical research 20041201

• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

  Diabetes & metabolism 20041201

• Identification of angiotensin converting enzyme 2 in the rodent retina.

  Current eye research 20041201

• On-line assay of the S-enantiomers of enalapril, ramipril and pentopril using a sequential injection analysis/amperometric biosensor system.

  Journal of pharmaceutical and biomedical analysis 20041119

• NO synthase inhibition increases aldosterone in humans.

  Hypertension (Dallas, Tex. : 1979) 20041101

• The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes.

  Kidney international. Supplement 20041101

• Proteinuria predicting outcome in renal disease: nondiabetic nephropathies (REIN).

  Kidney international. Supplement 20041101

• Vascular effects of simvastatin combined with ramipril in hypercholesterolemic patients with coronary artery disease, compared with simvastatin alone: a randomized, double-blind, placebo-controlled, crossover study.

  Atherosclerosis 20041101

• [ACE inhibitor therapy until end of life?].

  Deutsche medizinische Wochenschrift (1946) 20041029

• Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.

  American heart journal 20041001

• Provision of cardiovascular protection by ACE inhibitors: a review of recent trials.

  Current medical research and opinion 20041001

• Acute pancreatitis due to ramipril therapy.

  Postgraduate medical journal 20041001

• A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension.

  Blood pressure monitoring 20041001

• [Renoprotective effect of ramipril in children with chronic renal failure--the experience of one centre].

  Srpski arhiv za celokupno lekarstvo 20041001

• Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinediones.

  Diabetes technology & therapeutics 20041001

• Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).

  Diabetes, nutrition & metabolism 20041001

• [Can coronary risks be further reduced?].

  Presse medicale (Paris, France : 1983) 20040925

• Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.

  Circulation 20040914

• Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes.

  Current opinion in cardiology 20040901

• Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.

  Diabetologia 20040901

• Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).

  American heart journal 20040901

• Trial finds low dose ramipril does not reduce cardiovascular or renal events in people with type 2 diabetes and albuminuria.

  Evidence-based cardiovascular medicine 20040901

• Simvastatin combined with ramipril treatment in hypercholesterolemic patients.

  Hypertension (Dallas, Tex. : 1979) 20040801

• Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat.

  Journal of cardiovascular pharmacology 20040801

• Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.

  Kidney international 20040801

• Old antihypertensives and new diabetes.

  Journal of hypertension 20040801

• Protection against stroke and dementia: an update on the latest clinical trial evidence.

  Current hypertension reports 20040801

• Can young adult patients with proteinuric IgA nephropathy perform physical exercise?

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20040801

• The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.

  Journal of clinical hypertension (Greenwich, Conn.) 20040801

• Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?

  Annals of internal medicine 20040720

• Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective.

  Swiss medical weekly 20040710

• Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040701

• Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials.

  American heart journal 20040701

• Ramipril: clinical and economic benefits.

  Internal medicine journal 20040701

• Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.

  Circulation research 20040625

• Cardiac angiotensin is upregulated in the hearts of unstable angina patients.

  Circulation research 20040625

• Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.

  Journal of the American College of Cardiology 20040616

• Left ventricular hypertrophy: a 'factor of risk': mass is reversible, but is the risk?

  Journal of the American College of Cardiology 20040616

• Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.

  Acta pharmacologica Sinica 20040601

• Effect of ramipril on postrevascularization prevalence of angina and quality of life.

  International journal of cardiology 20040601

• Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.

  The Journal of the Association of Physicians of India 20040601

• Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.

  Circulation 20040511

• Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.

  Journal of the American College of Cardiology 20040505

• Ischemic preconditioning in coronary heart disease: a therapeutic golden fleece?

  Journal of the American College of Cardiology 20040505

• NPHS2 mutation associated with recurrence of proteinuria after transplantation.

  Pediatric nephrology (Berlin, Germany) 20040501

• The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.

  European journal of clinical pharmacology 20040501

• Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.

  American journal of hypertension 20040501

• Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.

  Expert opinion on pharmacotherapy 20040501

• Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20040501

• Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease.

  Cardiovascular drugs and therapy 20040501

• Losartan-ramipril combination treatment.

  The Journal of the Association of Physicians of India 20040501

• The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs.

  European journal of pharmacology 20040405

• An unusual cause of exertional leg pain.

  Current sports medicine reports 20040401

• Preventing type II diabetes mellitus.

  Journal of clinical pharmacology 20040401

• Bradykinin and matrix metalloproteinases are involved the structural alterations of rat small resistance arteries with inhibition of ACE and NEP.

  Journal of hypertension 20040401

• Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function.

  Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20040401

• Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats.

  Biochemical and biophysical research communications 20040326

• Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?

  Current medical research and opinion 20040301

• Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.

  Journal of hypertension 20040301

• Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20040301

• [Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].

  Nihon rinsho. Japanese journal of clinical medicine 20040301

• [Hypertensive nephrosclerosis].

  Nihon rinsho. Japanese journal of clinical medicine 20040301

• Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).

  The Journal of the Association of Physicians of India 20040301

• Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

  BMJ (Clinical research ed.) 20040227

• [Preventive therapy with ACE inhibitors for coronary patients].

  Orvosi hetilap 20040227

• [Is the supplementation with antioxidants effective in the treatment of atherosclerosis?].

  Deutsche medizinische Wochenschrift (1946) 20040213

• Modification of radiation injury by ramipril, inhibitor of angiotensin-converting enzyme, on optic neuropathy in the rat.

  Radiation research 20040201

• Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure.

  Journal of cardiac failure 20040201

• Timing of drug treatment is crucial.

  BMJ (Clinical research ed.) 20040117

• Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.

  Circulation research 20040109

• Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity.

  Circulation 20040106

• Angiotensin II and the fibroproliferative response to acute lung injury.

  American journal of physiology. Lung cellular and molecular physiology 20040101

• Angiotensin II-dependent increased expression of Na+-glucose cotransporter in hypertension.

  American journal of physiology. Renal physiology 20040101

• Primary pericardial mesothelioma presenting as pericardial constriction: a case report.

  Heart (British Cardiac Society) 20040101

• Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.

  European heart journal 20040101

• What have we learned from the current trials?

  The Medical clinics of North America 20040101

• Cutaneous vasculitis secondary to ramipril.

  Journal of drugs in dermatology : JDD 20040101

• Neurohumoral stimulation in type-2-diabetes as an emerging disease concept.

  Cardiovascular diabetology 20040101

• A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].

  BMC nephrology 20040101

• Evidence-based cardiovascular care in the community: a population-based cross-sectional study.

  BMC family practice 20040101

• Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.

  Journal of nephrology 20040101

• [Case report: hypertension after stroke].

  Wiener medizinische Wochenschrift (1946) 20040101

• Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspective.

  PharmacoEconomics 20040101

• Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20040101

• Renal outcome in adults with renal insufficiency and irregular asymmetric kidneys.

  BMC nephrology 20040101

• [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)].

  Kardiologiia 20040101

• Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

  Drugs 20040101

• Prominent crista terminalis mimicking a right atrial mixoma: cardiac magnetic resonance aspects.

  European review for medical and pharmacological sciences 20040101

• [Vascular patient with high infarction risk. Does the AT-1 blocker protect as well as an ACE inhibitor?].

  MMW Fortschritte der Medizin 20031218

• Lack of male-female differences in disposition and esterase hydrolysis of ramipril to ramiprilat in healthy volunteers after a single oral dose.

  TheScientificWorldJournal 20031211

• [New possibilities in clinical use of angiotensin II receptor inhibitors].

  Orvosi hetilap 20031207

• The EUROPA trial.

  Lancet (London, England) 20031206

• Combine EUROPA and HOPE.

  Lancet (London, England) 20031206

• Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction.

  Pharmacological research 20031201

• Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients.

  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20031201

• [Progress in the prevention of type 2 diabetes].

  Wiener klinische Wochenschrift 20031128

• [Added organ protection at little cost. Double savings with ACE inhibitors].

  MMW Fortschritte der Medizin 20031127

• [Therapy of hypertension. Cost conscious prevention of complications].

  MMW Fortschritte der Medizin 20031120

• [Health care too costly? Saving more than 10 million euros in 2 months!].

  MMW Fortschritte der Medizin 20031120

• [Therapy of hypertension. Lasting organ protection moves into the foreground].

  MMW Fortschritte der Medizin 20031120

• Differential regulation of renin and Cox-2 expression in the renal cortex of C57Bl/6 mice.

  Pflugers Archiv : European journal of physiology 20031101

• Angiotensin-converting enzyme inhibitors and stroke prevention: what about the influence of atrial fibrillation and antithrombotic therapy?

  Stroke 20031101

• Ramipril-associated hepatotoxicity.

  Archives of pathology & laboratory medicine 20031101

• Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease.

  Archives of biochemistry and biophysics 20031101

• Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20031101

• Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats.

  Cardiovascular research 20031101

• Recommendations for the management of special populations: racial and ethnic populations.

  American journal of hypertension 20031101

• The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.

  Clinical nephrology 20031101

• [Fast and strong lowering of pressure. The newest sartan has passed the practice test].

  MMW Fortschritte der Medizin 20031030

• Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States.

  The American journal of medicine 20031015

• Fulminant pancreatitis associated with ramipril therapy.

  Pancreas 20031001

• [Is type-2 diabetes mellitus preventable?].

  Orvosi hetilap 20030928

• [Ramipril after myocardial infarct. Long lasting cardiovascular protective action].

  MMW Fortschritte der Medizin 20030925

• [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].

  MMW Fortschritte der Medizin 20030925

• Conundrum of the HOPE study: time of taking ramipril may account for lack of relation between blood pressure and outcome.

  BMJ (Clinical research ed.) 20030920

• ['Using chance, despite high NNT'].

  MMW Fortschritte der Medizin 20030918

• Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

  Lancet (London, England) 20030906

• Mast cell infiltration and chemokine expression in progressive renal disease.

  Kidney international 20030901

• Stroke prevention: indapamide, a forgotten option?

  Stroke 20030901

• Collapsing glomerulopathy coexisting with membranous glomerulonephritis in native kidney biopsies: a report of 3 HIV-negative patients.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20030901

• Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.

  The Mount Sinai journal of medicine, New York 20030901

• Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes.

  Cardiovascular research 20030901

• Effects of spironolactone and metoprolol on QT dispersion in heart failure.

  Japanese heart journal 20030901

• Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20030901

• Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20030901

• Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats.

  Life sciences 20030801

• Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats.

  Nephrology (Carlton, Vic.) 20030801

• Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study.

  Annals of internal medicine 20030715

• Summaries for patients. Preventing worsening kidney function in patients receiving peritoneal dialysis.

  Annals of internal medicine 20030715

• [Corner points of antihypertensive therapy in prediabetic state. Success with a combination].

  MMW Fortschritte der Medizin 20030710

• Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).

  Journal of the American Society of Nephrology : JASN 20030701

• The rationale and design of the AASK cohort study.

  Journal of the American Society of Nephrology : JASN 20030701

• Stevens-Johnson Syndrome associated with ramipril.

  International journal of dermatology 20030701

• Use of angiotensin-converting enzyme inhibitors after coronary artery bypass grafting in patients with diabetes mellitus.

  The American journal of cardiology 20030701

• Modulating atherosclerosis through inhibition or blockade of angiotensin.

  Clinical cardiology 20030701

• The telmisartan programme of research tO show Telmisartan End-organ proteCTION (PROTECTION) programme.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20030701

• Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.

  Yonsei medical journal 20030630

• More than just hype.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030624

• More than just hype.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030624

• More than just hype.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030624

• More than just hype.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030624

• [Improved protection of heart and kidneys in the hypertensive patient. ACE inhibitor and AT1 blocker combined?].

  MMW Fortschritte der Medizin 20030605

• Reduced tubular cation transport in diabetes: prevented by ACE inhibition.

  Kidney international 20030601

• Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis.

  Kidney international 20030601

• Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.

  Kidney international 20030601

• Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.

  Cardiovascular research 20030601

• Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.

  European journal of heart failure 20030601

• Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect.

  European journal of heart failure 20030601

• Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction.

  Journal of cardiac failure 20030601

• [Evaluation of psychosomatic symptomatology in hypertensive patients treated with lercanidipine (LERCAPSICO study)].

  Anales de medicina interna (Madrid, Spain : 1984) 20030601

• Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers--a gap in evidence-based medicine.

  The American journal of cardiology 20030522

• How cost-effective are new preventive strategies for cardiovascular disease?

  The American journal of cardiology 20030522

• The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.

  The American journal of cardiology 20030522

• Prevention and management of chronic heart failure in patients at risk.

  The American journal of cardiology 20030508

• Cardiomyocyte loss in experimental renal failure: prevention by ramipril.

  Kidney international 20030501

• Cardiovascular risk in patients with mild renal insufficiency.

  Kidney international. Supplement 20030501

• HOPE study impact on ACE inhibitors use.

  The Annals of pharmacotherapy 20030501

• Mechanisms of myocardial remodeling: ramiprilat blocks the expressional upregulation of protein kinase C-epsilon in the surviving myocardium early after infarction.

  Journal of cardiovascular pharmacology 20030501

• Square wave voltammetric determination of the angiotensin-converting enzyme inhibitors cilazapril, quinapril and ramipril in pharmaceutical formulations.

  Farmaco (Societa chimica italiana : 1989) 20030501

• Delayed diagnosis of angiotensin-converting enzyme (ACE) inhibitor induced angioedema and urticaria.

  Clinical and experimental dermatology 20030501

• [Relationship between regression of hypertensive left ventricular hypertrophy and improvement of coronary flow reserve].

  Zhonghua yi xue za zhi 20030425

• Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.

  Circulation 20030415

• More hype than HOPE.

  Hypertension (Dallas, Tex. : 1979) 20030401

• Parallel renal and extremity blood supply abnormalities in nonmodulation: responses to ACE inhibition.

  Hypertension (Dallas, Tex. : 1979) 20030401

• Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.

  Journal of human hypertension 20030401

• Initial findings of the AASK: African Americans with hypertensive kidney disease benefit from an ACE inhibitor.

  Cleveland Clinic journal of medicine 20030401

• [Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension].

  Harefuah 20030401

• [Administration of maximal or median doses of drugs in cardiovascular diseases?].

  Vnitrni lekarstvi 20030401

• Assessment of the effect of ramipril therapy on direct health care costs for first and recurrent strokes in high-risk cardiovascular patients using data from the Heart Outcomes Prevention Evaluation (HOPE) study.

  Clinical therapeutics 20030401

• Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis.

  Regulatory peptides 20030328

• [Hypertension and prediabetes. 'Don't trust anybody over 130/80'].

  MMW Fortschritte der Medizin 20030327

• Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.

  Circulation 20030311

• [Delaying and preventing type 2 diabetes mellitus].

  MMW Fortschritte der Medizin 20030310

• Antihypertensive drugs and renal protection.

  JAMA 20030305

• The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030304

• Ramipril use in Canada: HOPE or HYPE?

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030304

• General inhibition of renocortical cyclooxygenase-2 expression by the renin-angiotensin system.

  American journal of physiology. Renal physiology 20030301

• The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century.

  Diabetes research and clinical practice 20030301

• Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.

  Journal of the American Society of Nephrology : JASN 20030301

• Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study.

  Diabetes care 20030301

• Metformin-induced hemolytic anemia in a patient with glucose-6- phosphate dehydrogenase deficiency.

  Diabetes care 20030301

• Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

  Hypertension (Dallas, Tex. : 1979) 20030301

• Economic impact of ramipril on hospitalization of high-risk cardiovascular patients.

  The Annals of pharmacotherapy 20030301

• Ramipril for the prevention and treatment of cardiovascular disease.

  The Annals of pharmacotherapy 20030301

• Pharmacoeconomic implications of large multicenter clinical trials.

  The Annals of pharmacotherapy 20030301

• Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.

  International immunopharmacology 20030301

• Cost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study.

  Circulation 20030225

• Best bang for the buck?

  Current hypertension reports 20030201

• The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-beta expression.

  Journal of hypertension 20030201

• Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?

  Stroke 20030201

• Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.

  Kidney international 20030201

• Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats.

  Kidney international 20030201

• Renoprotection: clues from knockout models of rare diseases.

  Kidney international 20030201

• The antiproteinuric effect of high-dose ramipril: still an open question.

  Kidney international 20030201

• [Simvastatin-induced lichen planus pemphigoides].

  Annales de dermatologie et de venereologie 20030201

• ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial.

  Kidney international. Supplement 20030201

• [Competitive sports and dilated cardiomyopathy: the case of a 32-year-old soccer player with ventricular tachycardia].

  Deutsche medizinische Wochenschrift (1946) 20030124

• [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].

  MMW Fortschritte der Medizin 20030123

• Preventing stroke with ramipril--authors' reply.

  BMJ (Clinical research ed.) 20030104

• Treatment of arteriosclerosis.

  Deutsche medizinische Wochenschrift (1946) 20030103

• Diarrhea, nephrotic syndrome and hidradenitis suppurativa: an unusual case.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030101

• Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction?

  Stroke 20030101

• Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction.

  American heart journal 20030101

• Implementing guidelines in primary care: can population impact measures help?

  BMC public health 20030101

• Influence of diabetes mellitus on heart failure risk and outcome.

  Cardiovascular diabetology 20030101

• Blood pressure drugs may help prevent stroke.

  Mayo Clinic health letter (English ed.) 20030101

• The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned?

  Journal of clinical hypertension (Greenwich, Conn.) 20030101

• [Chronopharmacological approaches to the therapeutic prophylaxis of chronic cardiac insufficiency in type I diabetes mellitus].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101

• [Prevention of stroke: should high risk patients be treated with angiotensin II converting enzyme inhibitors without regard to their blood pressure levels? ].

  Lijecnicki vjesnik 20030101

• [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].

  Archivos de cardiologia de Mexico 20030101

• [Tongue angioedema associated with angiotensin-converting enzyme inhibitor (diagnosis, differential diagnosis, treatment)].

  Medicina (Kaunas, Lithuania) 20030101

• Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR).

  Cardiovascular diabetology 20030101

• Myocarditis related to Campylobacter jejuni infection: a case report.

  BMC infectious diseases 20030101

• [Arrhythmogenic dilated cardiomyopathy].

  Medicina (Kaunas, Lithuania) 20030101

• [Ramipril in elderly patients with mild and moderate hypertension. Clinical efficacy, effect on cerebral blood flow and intellectual functioning].

  Kardiologiia 20030101

• [Comparative assessment of antihypertensive effects of angiotensin-converting enzyme inhibitors ramipril and captopril in patients with hypertension in ambulatory settings].

  Kardiologiia 20030101

• Angiotensin-I-converting enzyme and its relatives.

  Genome biology 20030101

• Do ACE inhibitors have a real role in coronary artery disease?

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20030101

• [The status of atherosclerosis prevention in Austria].

  Wiener medizinische Wochenschrift (1946) 20030101

• Published pharmacoeconomic analyses: science or marketing?

  Internal medicine journal 20030101

• Clinical and economic benefits of ramipril: an Australian analysis of the HOPE study.

  Internal medicine journal 20030101

• Calciphylaxis in chronic, non-dialysis-dependent renal disease.

  BMC nephrology 20030101

• Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof.

  Cardiovascular diabetology 20030101

• Chronic nephropathies: individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model.

  Nephron. Clinical practice 20030101

• Spotlight on ramipril in the prevention of cardiovascular outcomes.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101

• ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101

• [Focal segmental glomerulosclerosis with IgA deposits in a patient with ulcerative colitis].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20030101

• Pharmacoeconomic aspects of patients treated by hemodialysis.

  Bratislavske lekarske listy 20030101

• Cardiovascular drugs and serum uric acid.

  Cardiovascular drugs and therapy 20030101

• Systemic hypertension in postmenopausal women: a clinical approach.

  Current hypertension reports 20021201

• ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.

  Hypertension (Dallas, Tex. : 1979) 20021201

• Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?

  Journal of hypertension 20021201

• Left and right coronary circulation in left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition.

  Circulation journal : official journal of the Japanese Circulation Society 20021201

• Cerebrovascular disease in type 2 diabetes mellitus.

  Neurology India 20021201

• Optimisation by experimental design of a capillary electrophoretic method for the separation of several inhibitors of angiotensin-converting enzyme using alkylsulphonates.

  Journal of chromatography. A 20021129

• Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

  JAMA 20021120

• Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction.

  The American journal of cardiology 20021115

• Liquid chromatography-mass spectrometry method for determination of ramipril and its active metabolite ramiprilat in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021105

• Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.

  Diabetes 20021101

• Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

  Diabetes care 20021101

• Inhibition of angiotensin-converting enzyme reduces susceptibility of hypertrophied rat myocardium to ventricular fibrillation.

  Circulation journal : official journal of the Japanese Circulation Society 20021101

• [ACE inhibitors for diabetic patients. passed the test on the heart and kidneys].

  MMW Fortschritte der Medizin 20021031

• Combined endpoints: can we use them?

  Statistics in medicine 20021015

• Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney.

  Journal of the American Society of Nephrology : JASN 20021001

• Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril.

  Journal of cardiovascular pharmacology 20021001

• Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on cardiac norepinephrine release: comparison between ischemic and nonischemic conditions.

  Journal of cardiovascular pharmacology 20021001

• Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP.

  Hypertension (Dallas, Tex. : 1979) 20021001

• Ramipril treatment alters Ca(2+) and K(+) channels in small mesenteric arteries from Wistar-Kyoto and spontaneously hypertensive rats.

  American journal of hypertension 20021001

• [Cost-effectiveness analysis of Ramipril treatment of patients at high-risk of cardiovascular events in Spain].

  Anales de medicina interna (Madrid, Spain : 1984) 20021001

• Ramipril treatment in a patient with glycogen storage disease I non-A.

  Journal of inherited metabolic disease 20021001

• Effect of high dose ramipril with or without indomethacin on glomerular selectivity.

  Kidney international 20020901

• [Primary prevention of diabetes mellitus by pharmacological intervention].

  Nihon rinsho. Japanese journal of clinical medicine 20020901

• Vitamins, antioxidants and endothelial function in coronary artery disease.

  Cardiovascular drugs and therapy 20020901

• Preventing stroke with ramipril. Results should have been presented in ways that help practising clinicians.

  BMJ (Clinical research ed.) 20020824

• Preventing stroke with ramipril. Benefits were considerably overstated.

  BMJ (Clinical research ed.) 20020824

• Preventing stroke with ramipril. Superiority of particular class of antihypertensive agent remains to be shown.

  BMJ (Clinical research ed.) 20020824

• Preventing stroke with ramipril. Presentation of data is misleading.

  BMJ (Clinical research ed.) 20020824

• [Dangerous plaque often symptom-free. ACE inhibitors prevent rupture].

  MMW Fortschritte der Medizin 20020822

• Effect of long-term therapy with ramipril in high-risk women.

  Journal of the American College of Cardiology 20020821

• Chronic hydroxymethylglutaryl coenzyme a reductase inhibition and endothelial function of the normocholesterolemic rat: comparison with angiotensin-converting enzyme inhibition.

  Journal of cardiovascular pharmacology 20020801

• Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension.

  Clinical science (London, England : 1979) 20020801

• Cost-effectiveness of the treatment of heart failure with ramipril: a Spanish analysis of the AIRE study.

  European journal of heart failure 20020801

• Using ACE inhibitors appropriately.

  American family physician 20020801

• Ramipril prior to thrombolysis attenuates the early increase of PAI-1 in patients with acute myocardial infarction.

  Thrombosis and haemostasis 20020801

• Successful blood pressure control in the African American Study of Kidney Disease and Hypertension.

  Archives of internal medicine 20020722

• Who is fooling us?

  Lancet (London, England) 20020706

• Decreased susceptibility of cardiac function to hypoxia-reoxygenation in renin-angiotensinogen transgenic rats.

  American journal of physiology. Regulatory, integrative and comparative physiology 20020701

• Angiotensin-converting enzyme inhibitors and diarrhea.

  Journal of clinical gastroenterology 20020701

• Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.

  Journal of hypertension 20020701

• [Prevention of type II diabetes by inhibiting the renin-angiotensin system].

  Revue medicale de Liege 20020701

• Ramipril and cardiovascular risk reduction.

  Circulation 20020625

• Blood pressure and cardiovascular risk in the HOPE study.

  Lancet (London, England) 20020615

• Blood pressure and cardiovascular risk in the HOPE study.

  Lancet (London, England) 20020615

• Effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis.

  Current hypertension reports 20020601

• Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression.

  American journal of physiology. Regulatory, integrative and comparative physiology 20020601

• Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.

  Kidney international 20020601

• The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE study.

  Journal of internal medicine 20020601

• Severe angioedema induced by angiotensin converting enzyme inhibitors: role of precipitating factors.

  The Journal of dermatology 20020601

• [New indications. ACE inhibitor is now included in coronary heart disease therapy].

  MMW Fortschritte der Medizin 20020502

• Class benefits of AT(1) antagonists in Type 2 diabetes with nephropathy.

  Expert opinion on pharmacotherapy 20020501

• Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats.

  American journal of hypertension 20020501

• Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.

  The Canadian journal of cardiology 20020501

• [Diabetes mellitus and stroke].

  Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20020501

• Blood pressure drug helps prevent stroke.

  Health news (Waltham, Mass.) 20020501

• Spectrophotometric and AAS determination of ramipril and enalapril through ternary complex formation.

  Journal of pharmaceutical and biomedical analysis 20020415

• Risk reduction for stroke and coronary events.

  Lancet (London, England) 20020406

• Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with kidney failure.

  American journal of physiology. Renal physiology 20020401

• [Experience with Ramipril (Triatec(R)) in the treatment of glaucomatous neuropathy].

  Journal francais d'ophtalmologie 20020401

• ACE inhibition and atherogenesis.

  Canadian journal of physiology and pharmacology 20020401

• The angiotensin-converting enzyme gene I/D polymorphism and heart rate variability following acute myocardial infarction.

  Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20020401

• [Assessment of acute blood pressure variability during a stress test].

  Annales de cardiologie et d'angeiologie 20020401

• Preventing stroke.

  BMJ (Clinical research ed.) 20020323

• Use of ramipril in preventing stroke: double blind randomised trial.

  BMJ (Clinical research ed.) 20020323

• Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes.

  The Medical journal of Australia 20020318

• [Therapy of hypertension with ACE inhibitors. One third fewer cases of diabetes].

  MMW Fortschritte der Medizin 20020307

• Role of renal nerves in stimulation of renin, COX-2, and nNOS in rat renal cortex during salt deficiency.

  American journal of physiology. Renal physiology 20020301

• Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis.

  Atherosclerosis 20020301

• [ACE inhibitors in high risk heart patients. Primary analysis of the HOPE study].

  Der Internist 20020301

• Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20020301

• Blockade of endothelial enzymes: new therapeutic targets.

  Journal of human hypertension 20020301

• Systemic immunosuppression fails to suppress cardiac cytokine induction in pressure overload hypertrophy in rats.

  Immunobiology 20020301

• Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment.

  Circulation 20020205

• Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.

  Journal of molecular and cellular cardiology 20020201

• Comparative effects of the dual ACE-NEP inhibitor MDL-100,240 and ramipril on hypertension and cardiovascular disease in endogenous angiotensin II-dependent hypertension.

  American journal of hypertension 20020201

• [The plasma levels of proinsulin and true insulin and the effects of ramipril in hypertension].

  Zhonghua nei ke za zhi 20020201

• Blood pressure drug may prevent diabetes in some people.

  Mayo Clinic health letter (English ed.) 20020201

• 'Preemptive strike' heart medications. A.C.E. inhibitors gain new ground as multi-purpose cardiac drugs.

  Heart advisor 20020201

• Angiotensin II and trials of cardiovascular outcomes.

  The American journal of cardiology 20020124

• From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis.

  The American journal of cardiology 20020124

• The 24-hour blood pressure pattern: does it have implications for morbidity and mortality?

  The American journal of cardiology 20020124

• Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.

  Circulation 20020122

• Effect of ramipril and vitamin E on atherosclerosis.

  Circulation 20020115

• Ramipril and risk of diabetes.

  JAMA 20020109

• Ramipril and risk of diabetes.

  JAMA 20020109

• Role of angiotensin II in dynamic renal blood flow autoregulation of the conscious dog.

  The Journal of physiology 20020101

• Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia.

  British journal of pharmacology 20020101

• Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice.

  Diabetes, obesity & metabolism 20020101

• What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE.

  Diabetes, obesity & metabolism 20020101

• Reducing the risk of stroke in diabetes: what have we learned that is new?

  Diabetes, obesity & metabolism 20020101

• A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the 'Healing and Early Afterload Reducing Therapy' study.

  Clinical genetics 20020101

• Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.

  Clinical pharmacokinetics 20020101

• Is there a clinically significant gender bias in post-myocardial infarction pharmacological management in the older (>60) population of a primary care practice?

  BMC family practice 20020101

• Ramipril: a review of its use in the prevention of cardiovascular outcomes.

  Drugs 20020101

• Results from the TIP (Tritace in Proteinuria) intensified monitoring project.

  Kidney & blood pressure research 20020101

• Losartan and diabetic nephropathy: commentaries on the RENAAL study.

  Cardiovascular diabetology 20020101

• [Respiratory and renal functions and blood electrolytic composition in patients with pulmonary tuberculosis in the treatment of heart failure].

  Problemy tuberkuleza 20020101

• HOPE in PROGRESS--a tale of two trials: blood pressure reduction or drug mechanism?

  The American journal of geriatric cardiology 20020101

• Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.

  Journal of nephrology 20020101

• Tolerability of 10 mg of ramipril in normotensive Indian patients.

  The National medical journal of India 20020101

• Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.

  Diabetes/metabolism research and reviews 20020101

• Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.

  Cardiovascular diabetology 20020101

• Effects of ramipril therapy on some components of insulin resistance syndrome in patients with essential hypertension.

  Medicinski pregled 20020101

• Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker.

  Clinical hemorheology and microcirculation 20020101

• [Clinical sequelae of tissue angiotensin converting enzyme inhibition: practicability of use in ischemic heart disease].

  Kardiologiia 20020101

• Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20020101

• Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction.

  American heart journal 20011201

• ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy.

  Journal of the American Society of Nephrology : JASN 20011201

• Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

  Hypertension (Dallas, Tex. : 1979) 20011201

• Blood-pressure reduction and cardiovascular risk in HOPE study.

  Lancet (London, England) 20011201

• [Renal failure and cardiovascular risk. Increased borderline serum creatinine--a warning sign?].

  MMW Fortschritte der Medizin 20011129

• Simvastatin reverses impaired regulation of renal oxygen consumption in congestive heart failure.

  American journal of physiology. Renal physiology 20011101

• The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20011101

• Prevention, protection, and the intrarenal renin-angiotensin systems.

  Seminars in nephrology 20011101

• Sertraline-induced hypoglycemia.

  The Annals of pharmacotherapy 20011101

• Effect of ramipril in a patient with glycogen storage disease type I and nephrotic-range proteinuria.

  Journal of inherited metabolic disease 20011101

• [Late-appearing cholestatic icterus after a month of treatment with ticlopidine].

  Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20011101

• [Atherosclerosis. High ACE activity in plaque: risk of rupture!].

  MMW Fortschritte der Medizin 20011025

• Ramipril and the development of diabetes.

  JAMA 20011017

• [Prediction, screening and treatment of renal complications of diabetes].

  La Revue du praticien 20011015

• [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].

  La Revue du praticien 20011015

• [Preventing cardiovascular diseases. Discovering the optimal approach].

  MMW Fortschritte der Medizin 20011011

• Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.

  Circulation 20011002

• Clinical trials report. The effect of Ramipril versus Amlodipine on renal outcomes in hypertension nephrosclerosis.

  Current hypertension reports 20011001

• [Achieving vascular protection. ACE inhibitor lowers not only blood pressure].

  MMW Fortschritte der Medizin 20010906

• [Ramipril can do more. Halting progression of atherosclerosis].

  MMW Fortschritte der Medizin 20010906

• Can ACE inhibitor therapy prevent end-stage renal failure?

  The Medical journal of Australia 20010903

• The Heart Outcomes Prevention Evaluation study: angiotensin-converting enzyme inhibitors: are their benefits a class effect or do individual agents differ?

  Current opinion in nephrology and hypertension 20010901

• Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.

  The Journal of pharmacology and experimental therapeutics 20010901

• Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.

  British journal of pharmacology 20010901

• Enantioseparation of the anticoagulant drug phenprocoumon in capillary electrophoresis with UV and laser-induced fluorescence detection and application of the method to urine samples.

  Electrophoresis 20010901

• What is the relevance of the HOPE study in general practice?

  International journal of clinical practice 20010901

• What is the best treatment for slowing the progression to end-stage renal disease (ESRD) in African Americans with hypertensive nephropathy?

  The Journal of family practice 20010901

• Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression.

  Pflugers Archiv : European journal of physiology 20010901

• Angiotensin II receptor blockers and cardiovascular outcomes: the evidence now and in the future.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20010901

• [Diabetic nephropathy. Smoking also damages the kidney].

  MMW Fortschritte der Medizin 20010823

• Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway.

  Circulation 20010821

• Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus.

  Cardiovascular research 20010815

• The HOPE study: comparison with other trials of secondary prevention.

  European heart journal 20010801

• HOPE for patients with Type 2 diabetes: an application of the findings of the MICRO-HOPE substudy in a British hospital diabetes clinic.

  Diabetic medicine : a journal of the British Diabetic Association 20010801

• [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats].

  Archives des maladies du coeur et des vaisseaux 20010801

• Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study.

  Circulation 20010731

• Simultaneous determination of hydrochlorothiazide and several inhibitors of angiotensin-converting enzyme by capillary electrophoresis.

  Journal of chromatography. A 20010727

• Prevention of strokes.

  Current atherosclerosis reports 20010701

• Combined angiotensin converting enzyme inhibition and angiotensin AT(1) receptor blockade up-regulates myocardial AT(2) receptors in remodeled myocardium post-infarction.

  Cardiovascular research 20010701

• Bradykinin metabolism in the isolated perfused rabbit heart.

  Journal of hypertension 20010701

• Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation.

  Hypertension (Dallas, Tex. : 1979) 20010701

• Right atrial function in hypertensive patients: effects of antihypertensive therapy.

  Journal of human hypertension 20010701

• Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.

  Diabetologia 20010701

• Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction.

  Journal of the American College of Cardiology 20010615

• [Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study].

  Deutsche medizinische Wochenschrift (1946) 20010615

• Combined angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling.

  Circulation 20010612

• Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

  JAMA 20010606

• Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.

  Circulation research 20010525

• Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO.

  American journal of physiology. Renal physiology 20010501

• Cost effectiveness of ramipril treatment for cardiovascular risk reduction.

  Heart (British Cardiac Society) 20010501

• Role of renocortical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion.

  Journal of the American Society of Nephrology : JASN 20010501

• Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes.

  Diabetes care 20010501

• Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding?

  The Canadian journal of cardiology 20010501

• ACE inhibitor inhibits atherosclerosis.

  Harvard heart letter : from Harvard Medical School 20010501

• Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

  Annals of internal medicine 20010417

• The kidney in cardiovascular disease.

  Annals of internal medicine 20010417

• Summaries for patients. Trial of a drug to decrease the risk for heart disease in patients with mild kidney failure.

  Annals of internal medicine 20010417

• Recent clinical trial highlights in hypertension.

  Current hypertension reports 20010401

• Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure.

  Journal of the American College of Cardiology 20010401

• Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed.

  Journal of cardiovascular pharmacology 20010401

• Ask the doctor. Recently, I read that the ACE inhibitor ramipril is very good at preventing heart problems, particularly in people with diabetes. I'm diabetic, and for years I have been on a different ACE inhibitor (lisinopril). Should I be taking ramipril instead?

  Harvard heart letter : from Harvard Medical School 20010401

• Use of 7-fluoro-4-nitrobenzo-2-oxo-1,3-diazole (NBD-F) for the determination of ramipril in tablets and spiked human plasma.

  Farmaco (Societa chimica italiana : 1989) 20010401

• An ACE inhibitor to coronary patients: ramipril reduces mortality according to HOPE trial.

  Prescrire international 20010401

• [Atherosclerosis. High dosage ACE inhibitor keeps event rate under control].

  MMW Fortschritte der Medizin 20010329

• Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study.

  Annals of internal medicine 20010320

• The Heart Outcomes Prevention Evaluation Study.

  Current cardiology reports 20010301

• Low-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy.

  American journal of physiology. Heart and circulatory physiology 20010301

• Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery.

  Clinical science (London, England : 1979) 20010301

• Modulation of renal oxygen consumption by nitric oxide is impaired after development of congestive heart failure in dogs.

  Journal of cardiovascular pharmacology 20010301

• Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.

  Hypertension (Dallas, Tex. : 1979) 20010301

• What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?

  Cleveland Clinic journal of medicine 20010301

• Management of asymptomatic left ventricular dysfunction.

  Cleveland Clinic journal of medicine 20010301

• Effects of icatibant on the ramipril-induced decreased in renal lithium clearance in the rat.

  Naunyn-Schmiedeberg's archives of pharmacology 20010301

• Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

  Circulation 20010220

• Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase.

  Circulation 20010213

• Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor.

  British journal of pharmacology 20010201

• Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis.

  American heart journal 20010201

• [ACE inhibition in patients with myocardial infarct and ventricular dysfunction: inappropriate application of therapy standards in patient samples].

  Zeitschrift fur Kardiologie 20010201

• Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats.

  Diabetologia 20010201

• Intrarenal renin-angiotensin system contributes to tubular acidification adaptation following uninephrectomy.

  Experimental nephrology 20010101

• Potential role of eNOS in the therapeutic control of myocardial oxygen consumption by ACE inhibitors and amlodipine.

  Cardiovascular research 20010101

• Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies.

  Kidney international 20010101

• ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation.

  Arteriosclerosis, thrombosis, and vascular biology 20010101

• Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study.

  European heart journal 20010101

• Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent.

  Nephron 20010101

• A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage forms.

  Journal of pharmaceutical and biomedical analysis 20010101

• Voltammetric determination of benazepril and ramipril in dosage forms and biological fluids through nitrosation.

  Journal of AOAC International 20010101

• Hypertensive African Americans with kidney disease should seek advice from doctor about blood pressure medication.

  Ethnicity & disease 20010101

• Significance of exaggerated natriuresis after angiotensin AT1 receptor blockade or angiotensin- converting enzyme inhibition in obese Zucker rats.

  Clinical and experimental pharmacology & physiology 20010101

• [Severe hypoglycemia secondary to angiotensin-converting-enzyme inhibitors in the absence of diabetes mellitus. Report of a case].

  Gaceta medica de Mexico 20010101

• Differential regulation of cathepsin B and prorenin gene expression in renal juxtaglomerular cells.

  Kidney & blood pressure research 20010101

• [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].

  La Clinica terapeutica 20010101

• Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension: economic evaluation of Ramipril Efficacy in Nephropathy (REIN) Study for Germany from the perspective of statutory health insurance.

  PharmacoEconomics 20010101

• Study at up to 700 sites will build on landmark HOPE trial.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20010101

• The African American Study of Kidney Disease and Hypertension (AASK): new findings.

  Journal of clinical hypertension (Greenwich, Conn.) 20010101

• Renal insufficiency predicts cardiovascular disease in high-risk individuals: the benefit of ramipril in the HOPE study. Heart Outcomes and Prevention Evaluation.

  Journal of clinical hypertension (Greenwich, Conn.) 20010101

• Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.

  Journal of nephrology 20010101

• [Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].

  Problemy tuberkuleza 20010101

• Blacks with hypertension, renal insufficiency, and baseline proteinuria benefit more from ACE inhibition than from calcium channel blockade.

  Journal of clinical hypertension (Greenwich, Conn.) 20010101

• Modifying the natural history of atherosclerosis: the SECURE trial.

  International journal of clinical practice. Supplement 20010101

• Pharmacoeconomic impact of HOPE.

  International journal of clinical practice. Supplement 20010101

• Future perspectives and implications.

  International journal of clinical practice. Supplement 20010101

• Diabetes and the HOPE study: implications for macrovascular and microvascular disease.

  International journal of clinical practice. Supplement 20010101

• Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.

  Medicina 20010101

• European Society of Intensive Care Medicine 14th annual congress, 30 September-3 October 2001, Geneva, Switzerland.

  Critical care (London, England) 20010101

• [Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].

  Problemy tuberkuleza 20010101

• [Significance of angiotensin converting enzyme (ACE) in coronary circulation].

  Archivos de cardiologia de Mexico 20010101

• Dermatitis to captopril.

  Allergologia et immunopathologia 20010101

• [Reversible impairment of renal function during treatment with lisinopril, an ACE-inhibitor (case report)].

  Lijecnicki vjesnik 20010101

• New uses for old drug: reducing risk of heart attacks and strokes.

  FDA consumer 20010101

• The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES).

  Journal of the American College of Cardiology 20000315

• Protease inhibitors: current status and future prospects.

  Journal of medicinal chemistry 20000210

• Increased apoptosis in the heart of genetic hypertension, associated with increased fibroblasts.

  Cardiovascular research 20000201

• Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin.

  Journal of cardiovascular pharmacology 20000101

• Haemodynamic mechanisms of corticotropin (ACTH)-induced hypertension in the rat.

  Journal of hypertension 19991201

• ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function.

  European heart journal 19991101

• Role of nitric oxide in the control of cardiac oxygen consumption in B(2)-kinin receptor knockout mice.

  Hypertension (Dallas, Tex. : 1979) 19991001

• Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.

  The Journal of the Association of Physicians of India 19991001

• HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation.

  Lancet (London, England) 19990904

• Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.

  The American journal of cardiology 19990617

• Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression.

  Experimental nephrology 19990101

• Drug-induced Evans syndrome.

  Annals of internal medicine 19980215

• Prevention of left ventricular hypertrophy by ACE-inhibitor, ramipril in comparison with calcium-channel antagonist, felodipine.

  International journal of cardiology 19980131

• Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system.

  Cardiovascular research 19980101

• Role of kinins in the renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure.

  Kidney & blood pressure research 19980101

• [Bioenergetics of liver mitochondria after administration of ramipril in experimental diabetes mellitus].

  Bratislavske lekarske listy 19971201

• Cardiovascular effects of a low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.

  British journal of pharmacology 19970501

• [Angiotensin-converting enzyme inhibitor in the treatment of epirubicin-induced dilated cardiomyopathy].

  Ugeskrift for laeger 19970324

• Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.

  British journal of clinical practice. Supplement 19960701

• Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.

  European journal of pharmacology 19960613

• Functional activity and expression of the myocardial postreceptor adenylyl cyclase system in pressure overload hypertrophy in rat.

  Cardiovascular research 19960501

• Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy.

  Lancet (London, England) 19960203

• Quantitative assessment of daily physical activity levels in patients with chronic heart failure by measuring energy expenditure--effects of converting enzyme inhibitor therapy.

  Japanese circulation journal 19951001

• Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.

  Hypertension (Dallas, Tex. : 1979) 19950801

• Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.

  Hypertension (Dallas, Tex. : 1979) 19940601

• [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies].

  Zeitschrift fur Kardiologie 19940101

• The pharmacokinetic and pharmacodynamic interactions of ramipril with propranolol.

  European journal of clinical pharmacology 19930101

• Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers. off.

  British journal of clinical pharmacology 19920901

• Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.

  BMJ (Clinical research ed.) 19920411

• Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy.

  Kidney international 19920401

• Salt blocks the renal benefits of ramipril in diabetic hypertensive rats.

  Hypertension (Dallas, Tex. : 1979) 19910401

• The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension.

  Journal of cardiovascular pharmacology 19910101

• Metabolic effects of ramipril treatment in hypertensive subjects with non-insulin-dependent diabetes mellitus.

  Arzneimittel-Forschung 19900401

• Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.

  Cardiovascular drugs and therapy 19891201

• Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril.

  The American journal of cardiology 19870424

• Ramipril: review of pharmacology.

  The American journal of cardiology 19870424

• Disappearance of captopril-induced taste disturbance after substitution with angiotensin-converting-enzyme inhibitor HOE 498.

  Lancet (London, England) 19850302

• 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor.

  Arzneimittel-Forschung 19840101